MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01DD739E.3CD25FF0"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит данный браузер или редактор не поддерживает файлы веб-архива. Скачайте браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"UA168180101_C4B6.files/filelist.xml">
<link rel=3DEdit-Time-Data href=3D"UA168180101_C4B6.files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Царенко Ігор Анатолійович</o:Author>
  <o:LastAuthor>bravada</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2023-11-22T08:44:00Z</o:LastPrinted>
  <o:Created>2026-11-13T15:38:00Z</o:Created>
  <o:LastSaved>2026-11-13T15:38:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>9889</o:Words>
  <o:Characters>56373</o:Characters>
  <o:Company>Державний експертний центр</o:Company>
  <o:Lines>469</o:Lines>
  <o:Paragraphs>132</o:Paragraphs>
  <o:CharactersWithSpaces>66130</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"UA168180101_C4B6.files/item0001.xml"
target=3D"UA168180101_C4B6.files/props002.xml">
<link rel=3DthemeData href=3D"UA168180101_C4B6.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA168180101_C4B6.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"371">
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"macro"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" QFormat=3D"true" Name=3D=
"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Message Header"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" QFormat=3D"true" Name=3D=
"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" QFormat=3D"true" Name=3D=
"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" QFormat=3D"true" Name=3D=
"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Placeholder =
Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Yu Gothic";
	mso-font-charset:128;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 134676480 16 0 131073 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"\@TimesNewRoman";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 134676480 16 0 131073 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 1 Знак";
	mso-style-next:Обычный;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:center;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-font-kerning:0pt;
	mso-ansi-language:UK;
	mso-fareast-language:JA;
	mso-bidi-font-weight:normal;}
h2
	{mso-style-qformat:yes;
	mso-style-link:"Заголовок 2 Знак";
	mso-style-next:Обычный;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:UK;
	mso-fareast-language:JA;
	mso-bidi-font-weight:normal;}
h3
	{mso-style-qformat:yes;
	mso-style-link:"Заголовок 3 Знак";
	mso-style-next:Обычный;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:UK;
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	mso-bidi-font-weight:normal;
	font-style:italic;}
h4
	{mso-style-qformat:yes;
	mso-style-parent:"Заголовок 3";
	mso-style-link:"Заголовок 4 Знак";
	mso-style-next:Обычный;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:4;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:UK;
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	font-weight:normal;
	mso-bidi-font-style:italic;
	text-decoration:underline;
	text-underline:single;}
h5
	{mso-style-qformat:yes;
	mso-style-parent:"Заголовок 4";
	mso-style-link:"Заголовок 5 Знак";
	mso-style-next:Обычный;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:UK;
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	font-weight:normal;
	mso-bidi-font-style:italic;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-priority:99;
	mso-style-link:"Текст примечания Знак";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Верхний колонтитул Знак";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 249.3pt right 498.65pt;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Нижний колонтитул Знак";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 249.3pt right 498.65pt;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
span.MsoCommentReference
	{mso-style-priority:99;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-parent:"";
	color:#0563C1;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
tt
	{mso-style-noshow:yes;
	mso-style-parent:"";
	font-family:"Arial Unicode MS",serif;
	mso-ascii-font-family:"Arial Unicode MS";
	mso-fareast-font-family:"Arial Unicode MS";
	mso-hansi-font-family:"Arial Unicode MS";
	mso-bidi-font-family:"Arial Unicode MS";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Текст примечания";
	mso-style-link:"Тема примечания Знак";
	mso-style-next:"Текст примечания";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст выноски Знак";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	color:black;
	mso-fareast-language:JA;}
span.1
	{mso-style-name:"Заголовок 1 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 1";
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;
	mso-fareast-language:JA;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.2
	{mso-style-name:"Заголовок 2 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 2";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:JA;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.3
	{mso-style-name:"Заголовок 3 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 3";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;}
span.4
	{mso-style-name:"Заголовок 4 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 4";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	mso-bidi-font-style:italic;
	text-decoration:underline;
	text-underline:single;}
span.5
	{mso-style-name:"Заголовок 5 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 5";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:JA;
	mso-bidi-language:BO;
	font-style:italic;}
span.a
	{mso-style-name:"Текст выноски Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст выноски";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	color:black;
	mso-ansi-language:RU;
	mso-fareast-language:JA;}
span.a0
	{mso-style-name:"Текст примечания Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст примечания";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;
	mso-ansi-language:RU;
	mso-fareast-language:JA;}
span.a1
	{mso-style-name:"Тема примечания Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Тема примечания";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;
	mso-ansi-language:RU;
	mso-fareast-language:JA;
	font-weight:bold;}
p.EMEANormal, li.EMEANormal, div.EMEANormal
	{mso-style-name:"EMEA Normal";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"EMEA Normal Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-hyphenate:none;
	tab-stops:28.1pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.EMEANormalChar
	{mso-style-name:"EMEA Normal Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"EMEA Normal";
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
p.DefaultText, li.DefaultText, div.DefaultText
	{mso-style-name:"Default Text";
	mso-style-unhide:no;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-font-weight:bold;
	mso-bidi-font-style:italic;}
p.gtcbodytext, li.gtcbodytext, div.gtcbodytext
	{mso-style-name:gtcbodytext;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:12.0pt;
	margin-left:0cm;
	line-height:125%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.shorttext
	{mso-style-name:short_text;
	mso-style-unhide:no;}
p.gtctablespacebefore, li.gtctablespacebefore, div.gtctablespacebefore
	{mso-style-name:gtctablespacebefore;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.a2
	{mso-style-name:"Верхний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Верхний колонтитул";
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;
	mso-ansi-language:RU;
	mso-fareast-language:JA;}
span.a3
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Нижний колонтитул";
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"MS Mincho";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:black;
	mso-ansi-language:RU;
	mso-fareast-language:JA;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("UA168180101_C4B6.files/header.htm") fs;
	mso-footnote-continuation-separator:url("UA168180101_C4B6.files/header.htm=
") fcs;
	mso-endnote-separator:url("UA168180101_C4B6.files/header.htm") es;
	mso-endnote-continuation-separator:url("UA168180101_C4B6.files/header.htm"=
) ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:42.55pt 42.55pt 42.55pt 70.9pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-footer:url("UA168180101_C4B6.files/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:140539558;
	mso-list-type:hybrid;
	mso-list-template-ids:949366324 67698689 67698691 67698693 67698689 676986=
91 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:39.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:75.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:111.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:147.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:183.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:219.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:255.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:291.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:327.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:289169023;
	mso-list-type:hybrid;
	mso-list-template-ids:894624818 67698689 67698691 67698693 67698689 676986=
91 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:338628450;
	mso-list-type:hybrid;
	mso-list-template-ids:-2047963638 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:341974833;
	mso-list-type:hybrid;
	mso-list-template-ids:-1822797330 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:693961477;
	mso-list-type:hybrid;
	mso-list-template-ids:950591450 -973186756 68747267 68747269 68747265 6874=
7267 68747269 68747265 68747267 68747269;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0cm;
	mso-level-number-position:left;
	margin-left:1.0cm;
	text-indent:-1.0cm;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:904416272;
	mso-list-template-ids:-1987677306;}
@list l5:level1
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level2
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level3
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level4
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level5
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level6
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level7
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level8
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l5:level9
	{mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-18.0pt;}
@list l6
	{mso-list-id:916791222;
	mso-list-type:hybrid;
	mso-list-template-ids:1789938066 67698689 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7
	{mso-list-id:1344013583;
	mso-list-type:hybrid;
	mso-list-template-ids:1917760520 67698689 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:1534922163;
	mso-list-type:hybrid;
	mso-list-template-ids:-1756181216 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:1670862431;
	mso-list-type:hybrid;
	mso-list-template-ids:1943579496 67698689 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:1686709712;
	mso-list-type:hybrid;
	mso-list-template-ids:-1726192976 -1790413902 67698691 67698693 67698689 6=
7698691 67698693 67698689 67698691 67698693;}
@list l10:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:2017683419;
	mso-list-type:hybrid;
	mso-list-template-ids:663132952 67698689 67698691 67698693 67698689 676986=
91 67698693 67698689 67698691 67698693;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:2048871521;
	mso-list-type:hybrid;
	mso-list-template-ids:-1227823354 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13
	{mso-list-id:2054495941;
	mso-list-type:hybrid;
	mso-list-template-ids:-1545045470 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-bidi-font-family:"Times New Roman";}
table.MsoTableGrid
	{mso-style-name:"Сетка таблицы";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:UK;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU link=3D"#0563C1" vlink=3D"#954F72" style=3D'tab-interval:35=
.4pt'>

<div class=3DWordSection1>

<h1 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
color:windowtext'>ІНСТРУКЦІЯ<o:p></o:p></span></h1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK'>для медичного застосування лікарського засобу<o:p></o=
:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK'>Хуміра<sup>® <o:p></o:p></sup></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK'>(Humira<sup>®</sup>)</span></b><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK>Склад: </span></h2>

<h3 style=3D'margin-top:0cm'><span lang=3DUK style=3D'font-weight:normal'>д=
іюча
речовина:</span><span lang=3DUK> </span><span lang=3DUK style=3D'font-weigh=
t:normal;
font-style:normal;mso-bidi-font-style:italic'>адалімумаб;</span></h3>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'>1 попередньо наповнений однодозовий шприц містить 20 мг адалімумабу у 0=
,2
мл розчину;<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK style=3D'text-decoration:none;
text-underline:none'>допоміжні речовини:<b style=3D'mso-bidi-font-weight:no=
rmal'>
</b></span><i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;text-decor=
ation:
none;text-underline:none'>маніт (Е 421), полісорбат-80, вода для ін’єкцій.<=
o:p></o:p></span></i></h4>

<p class=3DMsoNormal><span class=3D2><span lang=3DUK style=3D'color:windowt=
ext;
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal><span class=3D2><span lang=3DUK style=3D'color:windowt=
ext;
mso-ansi-language:UK'>Лікарська форма.</span></span><tt><span lang=3DUK
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"MS Mincho";color:windowtext;mso-ansi-language:UK'> </span></tt><tt><span
lang=3DUK style=3D'mso-ansi-font-size:12.0pt;mso-bidi-font-size:11.0pt;font=
-family:
"Times New Roman",serif;mso-fareast-font-family:"MS Mincho";color:windowtex=
t;
mso-ansi-language:UK'>Розчин для ін’єкцій.</span></tt><tt><span lang=3DUK
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-fareast-f=
ont-family:
"MS Mincho";color:windowtext;mso-ansi-language:UK'><o:p></o:p></span></tt><=
/p>

<p class=3DMsoNormal><span class=3D3><span lang=3DUK style=3D'color:windowt=
ext;
mso-ansi-language:UK;font-weight:normal'>Основні фізико-хімічні властивості=
:</span></span><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'> </span></i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>б=
езбарвний
водний розчин від прозорого до опалесціюючого, практично вільний від сторон=
ніх
домішок.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Фармакотерапевтична
група. <o:p></o:p></span></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Імуносупресанти. Інгібітори фактора некрозу
пухлини-альфа. Адалімумаб. <o:p></o:p></span></p>

<p class=3DMsoNormal><span class=3D2><span lang=3DUK style=3D'color:windowt=
ext;
mso-ansi-language:UK;font-weight:normal'>Код АТХ</span></span><span lang=3D=
UK
style=3D'color:windowtext;mso-ansi-language:UK'> L04А В04.<b style=3D'mso-b=
idi-font-weight:
normal'><o:p></o:p></b></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Фармакологічні
властивості. <o:p></o:p></span></h2>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk152696939"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>®</sup></span></a><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK'> (адалімумаб</span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>) – це рекомбінантний імуноглобулін (IgG<sub>1</sub>)
людини, моноклональне антитіло, що містить тільки пептидні послідовності
людини. </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>була
створена за технологією фагового відображення, що дало змогу отримати
характерні тільки для людини варіабельні ділянки важких та легких ланцюгів,=
 які
проявляють свою специфічність щодо фактора некрозу пухлин (ФНП), а також ва=
жкий
ланцюг IgG<sub>1</sub> людини та послідовність легких ланцюгів каппа-типу. =
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>зв’язується з
високим ступенем спорідненості та зі специфічністю з розчинним ФНП-альфа, а=
ле
не з лімфотоксином (ФНП-бета). </span><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>продукується шляхом отримання рекомбінантної ДНК в
експресуючій системі клітин ссавців. Складається з 1300 амінокислот,
молекулярна маса становить близько 148 кілодальтонів. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Адалімумаб специфічно зв’язуєтьс=
я з
ФНП та нейтралізує біологічні ефекти ФНП, блокуючи його взаємодію з p55- та
p75-рецепторами ФНП на поверхні клітини. ФНП – це природний цитокін, який б=
ере
участь у нормальних запальних та імунних реакціях організму. Підвищені рівні
ФНП виявляють у синовіальній рідині пацієнтів з ревматоїдним артритом (РА),
ювенільним ревматоїдним артритом (ЮРА), псоріатичним артритом (ПсА) та
анкілозуючим спондилітом (АС). ФНП відіграє важливу роль у розвитку
патологічного запалення і руйнуванні тканин суглобів, що є характерним для =
цих
захворювань. Підвищені рівні ФНП виявляються також у псоріатичних бляшках.
Застосування лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>пацієнтам із бляшковим псоріазом може зменшити
потовщення епідермісу та інфільтрацію запальними клітинами. Взаємозв’язок м=
іж
цими фармакодинамічними ефектами та механізмом(-ами), через які </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>проявляє свою
клінічну ефективність, невідомий. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Адалімумаб модулює також біологі=
чні
реакції відповіді, що індукуються або регулюються ФНП, включаючи зміни рівн=
ів
молекул адгезії, відповідальних за міграцію лейкоцитів (ELAM-1, VCAM-1 та
ICAM-1 при IC<sub>50</sub> 1 – 2 &times; 10<sup>-10 </sup>М).<o:p></o:p></s=
pan></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Фармакодинаміка.</span></h3>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У пацієнтів з РА </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>спричиняла швид=
ке
зменшення, порівняно з початковими параметрами, показників гострої фази
запалення (С-реактивного протеїну (СРП), цитокінів сироватки крові (IL-6) та
швидкості осідання еритроцитів). Зниження рівнів СРП спостерігалося також і=
 у
пацієнтів з ЮРА, хворобою Крона, виразковим колітом та гнійним гідраденітом
поряд зі значним зменшенням експресії ФНП-альфа та запальних маркерів, таки=
х як
лейкоцитарний антиген (HLA-DR) та мієлопероксидаза (МРО), у товстому кишечн=
ику
пацієнтів з хворобою Крона. Також спостерігалося зниження рівнів матриксних
металопротеїназ (MMP-1 та MMP-3) у сироватці крові, які спричиняють
ремоделювання тканин, що лежить в основі руйнування хряща. У хворих з РА, П=
сА
та АС часто спостерігається від слабкого до помірного ступеня анемія та
лімфоцитопенія, а також підвищення кількості нейтрофілів та тромбоцитів. Пр=
и застосуванні
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>зазвичай спостерігається покращення цих гематологічних
ознак хронічного запалення. <o:p></o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Фармакокінетика.</span></h3>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Абсорбція
та розподіл<o:p></o:p></span></i></h5>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після одноразового підшкірного в=
ведення
40 мг лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>абсорбція та розподіл адалімумабу були повільними,
середня пікова концентрація в сироватці крові досягалася приблизно через 5 =
днів
після введення. Середня абсолютна біодоступність адалімумабу, розрахована в
трьох дослідженнях, після застосування одноразової дози 40 мг підшкірно
становила 64 %.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після одноразового внутрішньовен=
ного
введення у дозах від 0,25 до 10 мг/кг концентрації були пропорційні дозам.
Після застосування дози 0,5 мг/кг (приблизно 40 мг) кліренс був у діапазоні
11–15 мл/год, об’єм розподілу (Vss) становив від 5 до 6 л, середній
термінальний період напіввиведення становив приблизно 2 тижні. Концентрації
адалімумабу у синовіальній рідині у пацієнтів з РА становили 31–96 % від рі=
вня
в сироватці крові. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після підшкірного застосування <a
name=3D"_Hlk152697631">лікарського засобу </a></span><span style=3D'mso-boo=
kmark:
_Hlk152697631'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK'>Хуміра<sup>® </sup></span></span><span style=3D'mso-b=
ookmark:
_Hlk152697631'></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у дозі 40 мг 1 =
раз
на 2 тижні у пацієнтів з РА рівноважні концентрації становили від 5 мкг/мл =
(без
супутнього застосування<span style=3D'mso-spacerun:yes'>  </span>метотрекса=
ту) до
8–9 мкг/мл (з метотрексатом). Концентрації адалімумабу в сироватці крові у
рівноважному стані зростали майже пропорційно до підшкірно введених доз 20,=
 40
та 80 мг 1 раз на 2 тижні або щотижня. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після підшкірного застосування
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>у дозі 24 мг/м<sup>2</sup> (максимум 40 мг) 1 раз на 2
тижні у пацієнтів з поліартикулярним ЮРА віком від 4 до 17 років рівноважні
концентрації (показники вимірювались з 20-го по 48-й тиждень) становили 5,6=
 ±
5,6 мкг/мл (102 % CV – коефіцієнт варіації) без супутнього застосування
метотрексату та 10,9 ± 5,2 мкг/мл (47,7 % CV) з метотрексатом. <o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У дітей з
поліартикулярним ЮРА віком 2–4 роки та у дітей віком від 4 років, маса тіла
яких менше 15 кг, після застосування лікарського засобу </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Х=
уміра<sup>®
</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windo=
wtext;
mso-ansi-language:UK;mso-bidi-language:BO'>у дозі 24 мг/м<sup>2</sup> з
метотрексатом середнє значення рівноважних концентрацій становило 7,9 ± 5,6
мкг/мл (101 % CV).</span><span lang=3DUK style=3D'color:windowtext;mso-ansi=
-language:
UK;mso-bidi-language:BO'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після підшкірного застосування
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>у дозі 24 мг/м<sup>2</sup> (максимум 40 мг) 1 раз на 2
тижні у пацієнтів віком від 6 до 17 років з ентезит-асоційованим артритом
рівноважні концентрації (показники вимірювались на 24-му тижні) становили 8=
,8 ±
6,6 мкг/мл без супутнього застосування метотрексату та 11,8 ± 4,3 мкг/мл з
метотрексатом. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У дорослих пацієнтів із псоріазом
середня рівноважна концентрація становила 5 мкг/мл протягом монотерапії
адалімумабом у дозі 40 мг 1 раз на 2 тижні.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Після підшкірного застосування
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>у дозі 0,8 мг/кг (максимум 40 мг) 1 раз на 2 тижні у
дітей із хронічним бляшковим псоріазом рівноважні концентрації становили
приблизно 7,4 ± 5,8 мкг/мл (79&nbsp;% CV). <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>У пацієнтів з гнійним гідраденітом після введення
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>у дозі 160 мг на тижні 0 з наступним введенням 80 мг =
на
тижні 2 концентрація у сироватці крові становила приблизно від 7 до 8&nbsp;=
мкг/мл<span
style=3D'mso-spacerun:yes'>  </span>на тижні 2 та тижні 4. Середня рівноваж=
на
концентрація з тижня 12 до тижня 36 становила приблизно від 8 до 10 мкг/мл<=
span
style=3D'mso-spacerun:yes'>  </span>під час введення лікарського засобу </s=
pan><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у дозі 40 мг
кожного тижня.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Вплив адалімумабу на підлітків з гідраденітом було
визначено за допомогою фармакокінетичного моделювання та симуляції на основі
фармакокінетики при інших показаннях у дітей (бляшковий псоріаз, </span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>ювенільний ревматоїдний (ідіопатичний) артрит (ЮРА)</span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>, х</span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
color:windowtext;mso-ansi-language:UK'>вороба Крона (ХК) та ентезит-асоційо=
ваний
артрит</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windo=
wtext;
mso-ansi-language:UK;mso-bidi-language:BO'>). Рекомендований режим дозування
для підлітків з гідраденітом – 40 мг 1 раз на 2 тижні. Оскільки вплив
адалімумабу може залежати від маси тіла, підліткам з високою масою тіла та
недостатньою відповіддю на лікування можна застосовувати рекомендовану дозу=
 для
дорослих – по 40 мг один раз на тиждень.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У пацієнтів з хворобою Крона піс=
ля
введення лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>у дозі 80 мг на тижні 0 з наступним введенням 40 м=
г на
тижні 2 концентрація у сироватці крові становила приблизно 5,5 мкг/мл протя=
гом
індукційної терапії. Після введення лікарського засобу </span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Х=
уміра<sup>®
</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windo=
wtext;
mso-ansi-language:UK;mso-bidi-language:BO'>у дозі 160 мг на тижні 0 з насту=
пним
введенням 80 мг на тижні 2 концентрація у сироватці крові становила приблиз=
но
12 мкг/мл протягом індукційної терапії. Середня рівноважна концентрація
становила приблизно 7мкг/мл під час введення лікарського засобу </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у підтримуючій =
дозі
40 мг 1 раз на 2 тижні.</span><span lang=3DUK style=3D'color:windowtext;mso=
-ansi-language:
UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У дітей з хворобою Крона середнь=
ого
та високого ступеня активності початкова доза лікарського засобу </span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у відкритому до=
слідженні
становила 160/80 мг або 80/40 мг на тижнях 0 та 2 залежно від маси тіла. На
тижні 4 пацієнти були рандомізовані в співвідношенні 1 : 1 у групи, які
отримували залежно від маси тіла або стандартну дозу (40/20 мг 1 раз на 2
тижні), або низьку дозу (20/10 мг 1 раз на 2 тижні) для підтримуючої терапі=
ї.
Середня рівноважна концентрація становила приблизно 15,7 ± 6,6 мкг/мл<span
style=3D'mso-spacerun:yes'>  </span>на тижні 4 у пацієнтів з масою тіла 40 =
кг або
більше (160/80 мг) та 10,6 ± 6,1 мкг/мл у пацієнтів з масою тіла менше 40 кг
(80/40 кг).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У пацієнтів з виразковим колітом
після введення лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>у початковій дозі 160 мг на тижні 0 з наступним
введенням 80 мг на тижні 2 концентрація у сироватці крові становила приблиз=
но
12 мкг/мл протягом індукційної терапії. Середня рівноважна концентрація
становила приблизно 8 мкг/мл<span style=3D'mso-spacerun:yes'>  </span>під ч=
ас
введення лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>у підтримуючій дозі 40 мг 1 раз на 2 тижні.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:31.9pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>У пацієнтів з увеїтом після введ=
ення
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>у початковій дозі 80 мг на тижні 0 з наступним введен=
ням
40 мг 1 раз на 2 тижні, починаючи з тижня 1, середня рівноважна концентрація
становила приблизно від 8 до 10 мкг/мл.<o:p></o:p></span></p>

<p class=3DEMEANormal style=3D'text-align:justify'><span lang=3DUK style=3D=
'font-size:
12.0pt;mso-fareast-font-family:"MS Mincho";mso-ansi-language:UK;mso-fareast=
-language:
JA;mso-bidi-language:BO'>Вплив адалімумабу на стан дітей з увеїтом<span
style=3D'mso-spacerun:yes'>  </span>було визначено за допомогою
фармакокінетичного моделювання та симуляції на основі фармакокінетики при і=
нших
показаннях у дітей (бляшковий псоріаз, ювенільний ревматоїдний (ідіопатични=
й)
артрит (ЮРА), хвороба Крона (ХК) та ентезит-асоційований артрит). <o:p></o:=
p></span></p>

<p class=3DEMEANormal style=3D'text-align:justify'><span lang=3DUK style=3D=
'font-size:
12.0pt;mso-fareast-font-family:"MS Mincho";mso-ansi-language:UK;mso-fareast=
-language:
JA;mso-bidi-language:BO'>Немає клінічних даних про вплив початкової дози
адалімумабу на стан дітей віком до 6 років. Прогнозується, що за відсутності
метотрексату<span style=3D'mso-spacerun:yes'>  </span>початкова доза може п=
осилити
системний вплив адалімумабу.</span><span lang=3DUK style=3D'font-size:12.0p=
t;
mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Виведення<o:p></o:p></span></i></h5>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Популяційний фармакокінетичний
аналіз даних більше ніж 1300 пацієнтів з РА виявив тенденцію до підвищення
явного кліренсу адалімумабу з підвищенням маси тіла пацієнтів. З
урахуванням<span style=3D'mso-spacerun:yes'>  </span>поправок щодо різниці =
за масою
тіла було встановлено, що стать та вік пацієнта мають мінімальний вплив на
кліренс адалімумабу. Рівні вільного адалімумабу (не зв’язаного з антитілами=
 до
адалімумабу (ААА)) в сироватці крові були нижчими у пацієнтів, у яких виявл=
ялись
ААА. Не вивчалось застосування лікарського засобу </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Х=
уміра<sup>®
</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windo=
wtext;
mso-ansi-language:UK;mso-bidi-language:BO'>пацієнтам із порушеннями функцій
печінки та нирок. </span><span lang=3DUK style=3D'mso-fareast-font-family:T=
imesNewRoman;
color:windowtext;mso-ansi-language:UK;mso-fareast-language:EN-US'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Діти. </span></h3>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Безпека та ефективність застосування </span><span
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-bidi-language:BO;
mso-bidi-font-weight:bold'>лікарського засобу </span><span style=3D'mso-bid=
i-font-size:
12.0pt;color:windowtext;mso-bidi-font-weight:bold'>Хуміра<sup>® </sup></spa=
n><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>дітям за іншими показаннями, ніж ті, що зазначені у розділі «Показання»=
, не
встановлені.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Клінічні
характеристики.<o:p></o:p></span></h2>

<h3 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Показання.</span><s><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;text-transform:uppercase;font-=
weight:
normal'><o:p></o:p></span></s></h3>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Ювенільний ревматоїдний (ідіоп=
атичний)
артрит (ЮРА)</span></h4>

<h5 style=3D'margin-top:0cm'><span lang=3DUK>Поліартикулярний ювенільний ре=
вматоїдний
(ідіопатичний) артрит</span></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup>у комбінац=
ії з
метотрексатом показана для лікування активного поліартикулярного ювенільного
ідіопатичного артриту у дітей віком від 2 років, у яких не було адекватної
відповіді на терапію одним або кількома протиревматичними препаратами, що
модифікують перебіг захворювання (DMARDs).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>®=
 </sup>можна
застосовувати як монотерапію у разі непереносимості метотрексату або коли
продовження терапії метотрексатом є неприйнятним. Не було проведено дослідж=
ень
застосування лікарського засобу Хуміра<sup>® </sup>пацієнтам віком до 2 рок=
ів.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Ентезит-асоційований артрит</s=
pan></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Хуміра<sup>® </sup>показана для лікування активного
ентезит-асоційованого артриту у дітей віком від 6 років, які не відповідали=
 на
традиційну терапію, або при наявності непереносимості чи медичних протипока=
зань
до таких видів терапії.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Хвороба Крона (ХК) у дітей</sp=
an></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>показана=
 для
лікування хвороби Крона середнього та високого ступеня активності у дітей в=
іком
від 6 років, які не відповідали на традиційну терапію, включаючи первинну
нутритивну терапію, терапію кортикостероїдами та/або імуномодуляторами, або=
 при
наявності непереносимості чи медичних протипоказань до таких видів терапії.=
<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Бляшковий псоріаз (БП) у дітей=
</span></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Хуміра<sup>® </sup></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>показана=
 для
лікування хронічного бляшкового псоріазу з тяжким перебігом у дітей віком в=
ід 4
років, у яких не отримано клінічної відповіді або є протипоказання/
непереносимість місцевої терапії або фототерапії.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Увеїт у дітей</span></h4>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Х=
уміра<sup>®
</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windo=
wtext;
mso-ansi-language:UK;mso-bidi-language:BO'>показана для лікування хронічного
неінфекційного переднього увеїту у дітей віком від 2 років, які не відповід=
али
або мали н</span><span class=3Dshorttext><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>епереносимість традиційної те=
рапії
або яким традиційна терапія протипоказана.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Протипоказання.</span></h3>

<ul style=3D'margin-top:0cm' type=3Ddisc>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l11 level1 lfo2'>=
<span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO;mso-bidi-font-style:italic'>Підвищена чутливість до адалімумабу або=
 до
     будь-якого іншого компонента препарату. <o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l11 level1 lfo2'>=
<span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO;mso-bidi-font-style:italic'>Активний туберкульоз або інші тяжкі
     інфекції, такі як сепсис та опортуністичні інфекції (див. розділ «Особ=
ливості
     застосування»).<o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l11 level1 lfo2'>=
<span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO;mso-bidi-font-style:italic'>Помірна та тяжка серцева недостатність
     (III/IV клас за NYHA) (див. розділ «Особливості застосування»).<o:p></=
o:p></span></li>
</ul>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Взаємодія з іншими лікарськими
засобами та інші види взаємодій. </span></h3>

<ul style=3D'margin-top:0cm' type=3Ddisc>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l12 level1 lfo3;
     background:white'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
     mso-ansi-language:UK'>Лікарський засіб Хуміра<a name=3D"_Hlk152942161"=
><sup>®</sup></a><sup>
     </sup></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-an=
si-language:
     UK;mso-bidi-language:BO'>вивчали за участю пацієнтів з РА, ЮРА та ПсА,=
 які
     отримували препарат як монотерапію та одночасно з метотрексатом. Рівень
     формування антитіл був нижчим при одночасному застосуванні </span><span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK'>лік=
арського
     засобу Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
     12.0pt;mso-ansi-language:UK;mso-bidi-language:BO'>з метотрексатом
     порівняно з монотерапією. Введення </span><span lang=3DUK style=3D'mso=
-bidi-font-size:
     12.0pt;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></s=
pan><span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO'>без метотрексату призводило до збільшення рівня формування антитіл,
     збільшення кліренсу та зниження ефективності адалімумабу (див. розділ =
«</span><span
     lang=3DUK style=3D'mso-ansi-language:UK'>Фармакодинаміка»)</span><span
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO'>.<o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l12 level1 lfo3;
     background:white'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
     mso-ansi-language:UK;mso-bidi-language:BO'>Не рекомендується одночасне
     застосовування </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0=
pt;
     mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span><sp=
an
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO'>з анакінрою (див. розділ «Особливості застосування. Одночасне
     застосування з біологічними DMARDS або з антагоністами ФНП»).<o:p></o:=
p></span></li>
 <li class=3DMsoNormal style=3D'color:windowtext;mso-list:l12 level1 lfo3;
     background:white'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
     mso-ansi-language:UK;mso-bidi-language:BO'>Не рекомендується одночасне
     застосовування </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0=
pt;
     mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span><sp=
an
     lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:UK;mso-=
bidi-language:
     BO'>з абатацептом (див. розділ «Особливості застосування. Одночасне
     застосування з біологічними DMARDS або з антагоністами ФНП»).</span><b
     style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bid=
i-font-size:
     12.0pt;mso-ansi-language:UK'><o:p></o:p></span></b></li>
</ul>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3><span lang=3DUK>Особливості застосування.</span></h3>

<h4><span lang=3DUK>Можливість відстежування </span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>З метою
покращення контролю застосування біологічних препаратів необхідно чітко
фіксувати<b style=3D'mso-bidi-font-weight:normal'> </b>торговельну назву та=
 номер
серії введеного препарату</span><span lang=3DUK style=3D'color:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>. <o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Інфекції</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Пацієнти,
які приймають антагоністи ФНП, більш сприйнятливі до серйозних інфекцій.
Порушення функції легенів може збільшити ризик розвитку інфекцій. Тому паці=
єнти
повинні перебувати під ретельним наглядом щодо інфекцій, включаючи туберкул=
ьоз,
до, під час і після лікування лікарським засобом Хуміра</span><sup><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>®</span></sup><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:=
windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>. Оскільки виведення адалімумабу
може тривати до чотирьох місяців, моніторинг слід продовжувати протягом цьо=
го
періоду.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Не слід
застосовувати лікарський засіб </span><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup></span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>пацієнтам з активним інфекційним процесом, включаю=
чи
хронічні або локалізовані інфекції, поки інфекція не буде контрольована.</s=
pan><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'> У пацієнтів, які мають контакт із хворим на туберкульоз або повернулис=
я з
країн з високим рівнем захворюваності на туберкульоз або з ендемічних зон щ=
одо
мікозів, таких як гістоплазмоз, кокцидіоїдомікоз або бластомікоз, слід оцін=
ити
співвідношення користь/ризик до початку застосування лікарського засобу Хум=
іра<sup>®
</sup>(див. нижче «І<span style=3D'mso-bidi-font-style:italic'>нші опортуні=
стичні
інфекції»</span>).<span style=3D'mso-bidi-font-style:italic'><o:p></o:p></s=
pan></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Необхідно
провести повне обстеження та ретельно спостерігати за станом пацієнтів, у я=
ких
під час лікування </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарським засобом Хуміра<sup>® </su=
p></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>розвинулася нова інфекція. Слід<span
style=3D'mso-spacerun:yes'>  </span>припинити лікування при розвитку тяжкої
інфекції або сепсису та застосувати відповідні протимікробні або протигрибк=
ові
препарати, поки інфекція не буде контрольована. Лікарям слід бути обережними
при розгляді питання про призначення </span><span lang=3DUK style=3D'mso-bi=
di-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup=
>® </sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>пацієнтам з рецидивуючими інфекціями в анамнезі аб=
о з
фоновими станами (включаючи супутнє застосування імуносупресивних препараті=
в),
які можуть бути причиною схильності пацієнтів до інфекцій.<o:p></o:p></span=
></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Тяжкі
інфекції <o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Повідомл=
ялося
про серйозні інфекції, включаючи сепсис, спричинені бактеріальними,
мікобактеріальними, інвазивними грибковими, паразитарними, вірусними або ін=
шими
опортуністичними інфекціями, такими як лістеріоз, легіонельоз та пневмоцист=
оз,
у пацієнтів, які отримували </span><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
12.0pt;color:windowtext;mso-ansi-language:UK'>лікарський засіб Хуміра<sup>®=
</sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Інші
серйозні інфекції, виявлені під час клінічних випробувань, включають пневмо=
нію,
пієлонефрит, септичний артрит і септицемію. Повідомлялося про госпіталізацію
або летальні наслідки, пов’язані з інфекціями.<o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Туберкульоз<o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Повідомл=
ялося
про випадки реактивації та про розвиток нової інфекції туберкульозу, включа=
ючи
легеневу та нелегеневу форми (тобто дисемінований туберкульоз), у пацієнтів,
які отримували лікування препаратом Хуміра. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>До початку терапії <a
name=3D"_Hlk137420940">лікарським засобом Хуміра<sup>®</sup> </a>пацієнтів
потрібно ретельно обстежити щодо активного та неактивного (латентного)
туберкульозу. Обстеження повинно включати вичерпну оцінку анамнезу пацієнта=
 з
туберкульозом або відомості про можливі контакти з хворими на активний
туберкульоз і про попередню та/або супутню імуносупресивну терапію. Слід
провести всім пацієнтам до початку терапії шкірний туберкуліновий тест (про=
ба
Манту) та рентгенографію грудної клітки (можуть застосовуватися місцеві
рекомендації).</span><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'> <a name=3D"_Hlk138161371">Рекомендується, щоб проведення та результати=
 цих
тестів були записані в інформаційну картку пацієнта. Лікарям, які призначаю=
ть
препарати, слід пам’ятати про ризик хибно негативних результатів туберкулін=
ових
шкірних проб, особливо у тяжкохворих пацієнтів або у пацієнтів з ослабленим
імунітетом.<o:p></o:p></a></span></p>

<span style=3D'mso-bookmark:_Hlk138161371'></span>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Терапію лікарським засобом Ху=
міра<sup>®
</sup>не слід проводити, якщо діагностується активний туберкульоз (див. роз=
діл
«Протипоказання»). <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У всіх ситуаціях, описаних ни=
жче,
слід дуже ретельно оцінювати співвідношення користь/ризик терапії.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Якщо є підозра на прихований
туберкульоз, слід проконсультуватися з лікарем, який має досвід лікування
туберкульозу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У разі діагностики латентного
туберкульозу перед початком терапії лікарським засобом Хуміра<sup>® </sup>п=
отрібно
провести специфічне протитуберкульозне профілактичне лікування відповідно
до<span style=3D'mso-spacerun:yes'>  </span>місцевих рекомендацій. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Слід зважити на необхідність
застосування протитуберкульозного лікування перед початком терапії лікарськ=
им
засобом Хуміра<sup>® </sup>пацієнтам, які мають фактори ризику розвитку
туберкульозної інфекції, але в яких отримано негативний результат тесту на
латентний туберкульоз, та пацієнтам, які мали в анамнезі латентний або акти=
вний
туберкульоз і для яких не може бути підтверджене відповідне лікування. <o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk138161467"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Незважаючи на профілактичне протитуберкульозне лік=
ування,
випадки реактивації туберкульозу траплялися у пацієнтів, які отримували
препарат </span></a><span style=3D'mso-bookmark:_Hlk138161467'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Х=
уміра<sup>®</sup></span></span><span
style=3D'mso-bookmark:_Hlk138161467'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>. На тлі
лікування </span></span><span style=3D'mso-bookmark:_Hlk138161467'><span la=
ng=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарським
засобом <a name=3D"_Hlk152945311">Хуміра<sup>® </sup></a></span></span><span
style=3D'mso-bookmark:_Hlk152945311'></span><span style=3D'mso-bookmark:_Hl=
k138161467'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>у деяких пацієнтів, які раніше перенесли успішну
терапію активного туберкульозу, спостерігався повторний розвиток туберкульо=
зу</span></span><span
style=3D'mso-bookmark:_Hlk138161467'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>.</span></span><span
style=3D'mso-bookmark:_Hlk138161467'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o=
:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk138161467'></span>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Усіх пацієнтів потрібно
попередити про необхідність консультації лікаря у разі появи ознак, що
нагадують симптоми туберкульозу (наприклад, постійний кашель, зменшення маси
тіла, субфебрильна температура, апатія) під час або після лікування лікарсь=
ким
засобом Хуміра<sup>®</sup>.<o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Інші
опортуністичні інфекції<o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk138162131"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Протягом терапії лікарським засобом Хуміра<sup>® </sup>повідомлялося про
розвиток опортуністичних інфекцій, у тому числі інвазивних грибкових інфекц=
ій.
Іноді такі інфекції своєчасно не діагностувалися у пацієнтів, які приймали =
</span></a><span
style=3D'mso-bookmark:_Hlk138162131'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>антагоні=
сти
ФНП</span></span><span style=3D'mso-bookmark:_Hlk138162131'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>,=
 що
призводило до пізнього початку відповідного лікування та іноді завершувалося
летально. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk138162131'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Пацієнти, які застосовують блокатори ФНП, більш схильні до розвитку
серйозних грибкових інфекцій, таких як </span></span><span style=3D'mso-boo=
kmark:
_Hlk138162131'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>гістоплазмоз, кокцидіоїдомікоз,
бластомікоз, аспергільоз, кандидоз тощо. Терапію лікарським засобом Хуміра<=
sup>®</sup>
потрібно негайно припинити, якщо у </span></span><span style=3D'mso-bookmar=
k:
_Hlk138162131'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK'><span style=3D'mso-spacerun:yes'> </span>пацієнта
спостерігається розвиток лихоманки, нездужання, зменшення маси тіла, підвищ=
ення
пітливості, поява кашлю, задишки та/або інфільтратів у легенях або інших оз=
нак
серйозного системного захворювання (з шоком або без), та слід запідозрити
інвазивну грибкову інфекцію. Рішення щодо застосування емпіричної
протигрибкової терапії таким хворим слід приймати після консультації з фахі=
вцем
у сфері діагностики та лікування інвазивних грибкових інфекцій.</span></spa=
n><span
style=3D'mso-bookmark:_Hlk138162131'></span><i><span lang=3DUK style=3D'col=
or:windowtext;
mso-ansi-language:UK'><o:p></o:p></span></i></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Реактивація гепатиту</span><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK> </span></i><span lang=
=3DUK
style=3D'mso-bidi-font-style:normal'>В<i style=3D'mso-bidi-font-style:norma=
l'><o:p></o:p></i></span></h4>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk138162320"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Випадки реактивації гепатиту В траплялись у пацієн=
тів,
які приймали блокатори ФНП та були хронічними носіями вірусу гепатиту В (ВГ=
В),
тобто в яких було виявлено поверхневий антиген вірусу. Деякі випадки були
летальними. Перед початком лікування препаратом</span></a><span
style=3D'mso-bookmark:_Hlk138162320'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'> Хуміра<sup>®</sup> </span></=
span><span
style=3D'mso-bookmark:_Hlk138162320'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>пацієнти
повинні пройти тест на наявність ВГВ-інфекції. Пацієнтам з позитивним тесто=
м на
ВГВ-інфекцію рекомендується проконсультуватися з лікарем, який має досвід л=
ікування
гепатиту В.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk138162320'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Носії <a name=3D"_Hlk137422766">ВГВ</a>, які потре=
бують
терапії лікарським засобом </span></span><span style=3D'mso-bookmark:_Hlk13=
8162320'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>®</sup></span></span><span style=3D'mso-bookmark:_Hlk1381623=
20'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>, повинні перебувати під ретельним наглядом щодо п=
ояви
ознак і симптомів активної ВГВ-інфекції під час терапії та протягом кількох
місяців після її припинення. Немає адекватних даних щодо лікування пацієнті=
в,
які є носіями ВГВ, противірусними препаратами в поєднанні з антагоністами Ф=
НП
для запобігання реактивації ВГВ. Пацієнтам, у яких розвивається реактивація
ВГВ, слід припинити прийом </span></span><span style=3D'mso-bookmark:_Hlk13=
8162320'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>® </sup></span></span><span style=3D'mso-=
bookmark:
_Hlk138162320'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>та розпочати ефективну противіру=
сну
терапію з відповідним підтримуючим лікуванням.</span></span><span
style=3D'mso-bookmark:_Hlk138162320'></span><i><span lang=3DUK style=3D'col=
or:windowtext;
mso-ansi-language:UK'><o:p></o:p></span></i></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Неврологічні розлади</span></h=
4>

<p class=3DMsoNormal style=3D'background:white;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>При застосуванні блокаторів ФНП, у тому числі лікарсь=
кого
засобу Хуміра<sup>®</sup>, повідомлялося про поодинокі випадки появи або
загострення клінічних симптомів та/або радіографічних ознак демієлінізуючих
захворювань центральної нервової системи, включаючи розсіяний склероз, невр=
ит
зорового нерва та демієлінізуючі захворювання периферичної нервової системи=
, </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
color:windowtext;mso-ansi-language:UK;mso-fareast-language:UK'>включаючи
синдром Гійєна – Барре</span><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
color:windowtext;mso-ansi-language:UK'>. Лікарі, які призначають препарат, =
повинні
з обережністю розглядати можливість застосування лікарського засобу Хуміра<=
sup>®
</sup>пацієнтам із демієлінізуючими розладами центральної або периферичної
нервової системи, які спостерігалися раніше або нещодавно виникли; необхідно
припинити терапію лікарським засобом Хуміра<sup>® </sup>у разі виникнення
зазначених розладів. Відомо, що існує зв’язок між </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>інтермедіарним увеїтом та </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>д=
емієлінізуючими
розладами центральної нервової системи. Неврологічне обстеження необхідно
проводити пацієнтам з </span><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>неінфекційним
інтермедіарним увеїтом перед тим, як розпочати терапію </span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарським
засобом Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, та регулярно
протягом терапії, щоб оцінювати розвиток</span><span lang=3DUK style=3D'col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-font-weight:bold'> </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>д=
емієлінізуючих
розладів центральної нервової системи, які спостерігалися раніше чи нещодав=
но
виникли. </span><span lang=3DUK style=3D'color:windowtext;mso-ansi-language=
:UK;
mso-bidi-font-weight:bold'><span style=3D'mso-spacerun:yes'> </span></span>=
<span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'><o:p></o:p></span=
></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Алергічні реакції</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Під час
клінічних досліджень серйозні алергічні реакції, пов’язані з </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарським засобом Хуміра<sup>®</sup></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, виника=
ли
рідко. Несерйозні алергічні реакції, пов’язані з прийомом лікарського засобу
Хуміра</span><sup><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:=
windowtext;
mso-ansi-language:UK'>®</span></sup><span lang=3DUK style=3D'mso-bidi-font-=
size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, під час
клінічних досліджень були нечастими. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Повідомл=
ялося
про серйозні алергічні реакції, включаючи анафілаксію, після введення </spa=
n><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>®</sup></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>. При
виникненні анафілактичної реакції або іншої серйозної алергічної реакції
необхідно негайно припинити застосування </span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup=
>® </sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>і розпочати відповідну терапію.<o:p></o:p></span><=
/p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Імуносупресія</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Під час
клінічних досліджень </span><span lang=3DUK style=3D'mso-bidi-font-size:12.=
0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>у 64 пацієнтів з РА випадків пригнічення
гіперчутливості сповільненого типу, зниження рівнів імуноглобулінів або
кількісних змін ефекторних Т- та В-клітин, а також NK-клітин, моноцитів/мак=
рофагів
та нейтрофілів не спостерігалося.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Злоякісні новоутворення та
лімфопроліферативні захворювання </span></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>У контрольованих клінічних дослідженнях блокаторів ФНП
частіше повідомлялося про розвиток з</span><span lang=3DUK style=3D'mso-bid=
i-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>лоякісних
новоутворень, включаючи лімфому,</span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;color:windowtext;mso-ansi-language:UK'> у пацієнтів, які отримували
ФНП-блокатор, ніж у пацієнтів контрольної групи. Проте явище було рідкісним=
. У
постреєстраційний період повідомлялося про випадки лейкемії у пацієнтів, які
отримували антагоністи ФНП. Існує підвищений фоновий ризик розвитку лімфоми=
 і
лейкемії у пацієнтів з ревматоїдним артритом із тривалим перебігом та
високоактивним запальним процесом, що ускладнює оцінку ризику. Дані, що існ=
ують
на сьогодні, не дають змоги виключити ризик розвитку лімфоми, лейкемії та і=
нших
злоякісних новоутворень у пацієнтів, які отримують антагоністи </span><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'>ФНП.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
постреєстраційний період повідомлялося про окремі випадки розвитку злоякісн=
их
новоутворень, іноді з летальним наслідком, у дітей, підлітків та дорослих
пацієнтів молодого віку (до 22 років), які отримували лікування блокаторами=
 </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>ФНП (початок </span><span lang=3DUK style=3D'color:windowtext;mso-ansi-=
language:
UK'>терапії у віці &#8804; 18 років), включаючи адалімумаб.</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'> Приблизно в половині цих випадків злоякісними новоутвореннями були
лімфоми. Інші випадки були представлені різними видами злоякісних новоутвор=
ень,
зокрема такими, що</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> зазвичай пов’я=
зані
з </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtex=
t;
mso-ansi-language:UK'>імуносупресією. Не можна виключити ризик розвитку
злоякісних новоутворень у дітей та підлітків, які отримують антагоністи ФНП=
. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У постреєстраційний період у
пацієнтів, які застосовували адалімумаб, дуже рідко повідомлялося про розви=
ток
гепатолієнальної Т-клітинної лімфоми. Цей рідкісний тип лімфоми
характеризується дуже агресивним перебігом та зазвичай є летальним. Деякі з=
 цих
випадків гепатолієнальної Т-клітинної лімфоми на фоні прийому лікарського
засобу Хуміра<sup>® </sup>траплялися у дорослих пацієнтів молодого віку, які
отримували супутню терапію азатіоприном або 6-меркаптопурином для лікування
запальних захворювань кишечнику. Потенційний ризик одночасного застосування
азатіоприну або 6-меркаптопурину з лікарським засобом Хуміра<sup>® </sup>має
бути ретельно оцінений. Ризик розвитку гепатолієнальної Т-клітинної лімфоми=
 у
пацієнтів, які<span style=3D'mso-spacerun:yes'>  </span>приймають лікарський
засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'color:windowtext;
mso-ansi-language:UK'>, не</span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK'> можна виключати (див. розділ «Побіч=
ні
реакції»).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Досліджень щодо застосування
лікарського засобу Хуміра<sup>® </sup>пацієнтам зі злоякісними новоутворенн=
ями
в анамнезі або щодо продовження терапії лікарським засобом Хуміра<sup>® </s=
up>пацієнтів,
в яких розвинулося злоякісне новоутворення, не проводилося. Це потрібно
враховувати та з обережністю приймати рішення щодо призначення лікарського
засобу Хуміра<sup>® </sup>таким хворим (див. розділ «Побічні реакції»).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У всіх пацієнтів, особливо у
пацієнтів з інтенсивною імуносупресивною терапією в анамнезі та у пацієнтів=
 із
псоріазом, яким проводили PUVA-терапію, слід виключити наявність немеланомн=
ого
раку шкіри<span style=3D'mso-spacerun:yes'>  </span>до та протягом періоду
застосування лікарського засобу Хуміра<sup>®</sup>. Також повідомлялось про
випадки меланоми та карциноми з клітин Меркеля у пацієнтів, що отримували
лікування антагоністами ФНП, включаючи адалімумаб (див. розділ «Побічні
реакції»).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У пошуковому клінічному
дослідженні, в якому оцінювали застосування іншого ФНП-блокатора (інфліксим=
аб),
у пацієнтів із хронічним обструктивним захворюванням легень (ХОЗЛ) середньо=
го
та тяжкого ступеня повідомлялося про більш часті випадки виникнення
новоутворень, здебільшого у легенях, голові та на ділянці шиї, порівняно з
контрольною групою. Всі пацієнти довгий час були курцями. Тому необхідно з
обережністю застосовувати будь-які ФНП-блокатори пацієнтам із хронічною
обструктивною хворобою легень та пацієнтам із підвищеним ризиком виникнення
новоутворень на тлі паління. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Дотепер невідомо, чи впливає
застосування адалімумабу на ризик розвитку дисплазії або раку кишечнику. Усі
пацієнти з виразковим колітом, що входять до групи підвищеного ризику розви=
тку
дисплазії або раку кишечнику (наприклад пацієнти з довготривалим виразковим
колітом або первинним склерозуючим холангітом), або ті, хто мав в анамнезі
дисплазію або рак кишечнику, повинні підлягати регулярному обстеженню щодо
наявності дисплазії перед початком терапії та протягом перебігу всієї хворо=
би.
Обстеження має включати колоноскопію та біопсію відповідно до місцевих
рекомендацій.</span><span style=3D'color:windowtext'><o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Гематологічні розлади</span></=
h4>

<h4 style=3D'margin-top:0cm'><a name=3D"_Hlk138163764"><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;text-decoration:none;text-underline:none=
'>Рідко
при застосуванні блокаторів ФНП повідомлялося про розвиток панцитопенії,
включаючи апластичну анемію. При застосуванні лікарського засобу Хуміра<sup=
>® </sup>повідомлялося
про побічні реакції з боку системи крові, включаючи клінічно значущу цитопе=
нію
(наприклад тромбоцитопенію, лейкопенію). Усіх пацієнтів потрібно попередити=
 про
необхідність негайної консультації лікаря при появі симптомів, притаманних
захворюванням крові (таких як постійна гарячка, синці, кровотеча, блідість
шкіри та слизових оболонок), на тлі застосування лікарського засобу Хуміра<=
sup>®</sup>.
Слід розглянути необхідність припинення застосування лікарського засобу Хум=
іра<sup>®
</sup><span style=3D'mso-spacerun:yes'> </span>у разі підтвердження у паціє=
нта
серйозних порушень з боку крові.</span></a><span lang=3DUK style=3D'mso-bid=
i-font-size:
12.0pt;text-decoration:none;text-underline:none'><o:p></o:p></span></h4>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Вакцинація</span></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'>При проведенні дослідження за участю 226 дорослих пацієнтів з ревматоїд=
ним
артритом, які отримували лікування адалімумабом або плацебо, була отримана
подібна гуморальна відповідь на стандартну 23-валентну пневмококову вакцину=
 та
тривалентну вакцину проти вірусу грипу. Даних щодо вторинної передачі інфек=
ції
пацієнтам, які отримували живі вакцини та </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарський
засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'color:windowtext;
mso-ansi-language:UK'>, немає. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Для
пацієнтів дитячого віку рекомендовано провести всі необхідні щеплення, якщо=
 це<span
style=3D'mso-spacerun:yes'>  </span>можливо, згідно з календарем до початку=
 терапії
</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;
mso-ansi-language:UK'>лікарським засобом Хуміра<sup>®</sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Застосув=
ання
живих вакцин (наприклад БЦЖ-вакцина) немовлятам, які піддавалися впливу
адалімумабу внутрішньоутробно, не рекомендується протягом 5 місяців після
останньої ін’єкції адалімумабу матері у період вагітності.<o:p></o:p></span=
></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Хронічна серцева недостатність=
 (ХСН)</span></h4>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk138163948"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>У клінічних дослідженнях з іншим блокатором ФНП
повідомлялося про погіршення перебігу ХСН та підвищену смертність, пов’язан=
у із
ХСН. Повідомлялося також про випадки погіршення перебігу ХСН у пацієнтів, я=
кі
отримують терапію </span></a><span style=3D'mso-bookmark:_Hlk138163948'><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарським засобом Хуміра<sup>®</sup></span></span><span style=3D'mso-b=
ookmark:
_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>. </span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>®=
 </sup>слід
з обережністю застосовувати пацієнтам із серцевою недостатністю легкого сту=
пеня
<span style=3D'mso-bidi-font-style:italic'>(</span></span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span style=3D'mso-bidi-font-size:12.0=
pt;
color:windowtext;mso-bidi-font-style:italic'>I</span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>/<=
/span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span style=3D'mso-bidi-font-size:12.0=
pt;
color:windowtext;mso-bidi-font-style:italic'>II</span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'> к=
лас
згідно з </span></span><span style=3D'mso-bookmark:_Hlk138163948'><span
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-bidi-font-style:ita=
lic'>NYHA</span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>).=
 </span></span><span
style=3D'mso-bookmark:_Hlk138163948'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Хуміра<sup>® </sup><span
style=3D'mso-bidi-font-style:italic'>протипоказана пацієнтам із ХСН середнь=
ого та
тяжкого ступеня</span> (див. розділ «Побічні реакції»). Лікування лікарським
засобом Хуміра<sup>® </sup>необхідно припинити у разі виникнення у пацієнта
нових або погіршення наявних симптомів хронічної серцевої недостатності у
пацієнта.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk138163948'></span>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Аутоімунні процеси</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Лікуванн=
я </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарським засобом Хуміра<sup>® </sup></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>може спричинити появу аутоантитіл. Вплив тривалого
застосування </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;colo=
r:windowtext;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>на розвиток аутоімунних захворювань невідомий. Якщо
після початку терапії лікарським засобом Хуміра</span><sup><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>®=
</span></sup><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'> </span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK'>виникають симптоми, що нагадують вов=
чакоподібний
синдром, а також позитивні результати аналізу на антитіла до дволанцюгової<=
span
style=3D'mso-spacerun:yes'>  </span>ДНК, лікування лікарським засобом Хумір=
а<sup>®
</sup>необхідно припинити.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Одночасне застосування з біоло=
гічними
DMARDs або з антагоністами ФН<a name=3D"_Hlk152958540">П</a></span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Спостерігалися серйозні інфек=
ції
під час клінічних досліджень супутнього застосування анакінри та іншого
антагоніста ФНП – етанерцепту, що не мало терапевтичних переваг у порівнянн=
і з
монотерапією етанерцептом. З огляду на характер побічних явищ, що
спостерігалися під час комбінованого лікування етанерцептом та анакінрою,
подібна токсичність може розвинутися при комбінації анакінри та іншого
блокатора ФНП. Тому комбінація адалімумабу та анакінри не рекомендується.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO;mso-bidi-=
font-style:
italic'>Одночасне застосування адалімумабу з іншими біологічними DMARDs
(наприклад, анакінра та абатацепт) або з іншими антагоністами ФНП не
рекомендується з огляду на можливе підвищення ризику інфекцій та інших
потенційних фармакологічних взаємодій (див. розділ «</span><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Взаємодія з іншими лікарськ=
ими
засобами та інші види взаємодій»)</span><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO;mso-bidi-=
font-style:
italic'>.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Хірургічні втручання</span></h=
4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Доступні
обмежені дані щодо безпеки хірургічних процедур для пацієнтів, які отримуют=
ь </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-=
bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>. Тривал=
ий
період напіввиведення адалімумабу необхідно брати до уваги, якщо планується
хірургічне втручання. Пацієнта, який потребує хірургічного втручання та
знаходиться на лікуванні </span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарським засобом Хуміра<sup>®</sup=
></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>, потрібно ретельно обстежити на наявність інфекці=
й та
вжити необхідних заходів. Доступні обмежені дані щодо безпеки застосування
пацієнтам, які піддавались артропластиці під час терапії </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарським
засобом Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>. </span><i><sp=
an
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'><o:p></o:p></span=
></i></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Непрохідність тонкої кишки</sp=
an></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Відсутні=
сть
відповіді на лікування хвороби Крона може свідчити про наявність фіксованої
фіброзної стриктури, яка вимагає лікування хірургічним шляхом. Доступні дані
дають змогу вважати, що лікування </span><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>лікарським засобом Хуміра<sup=
>®</sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'> не спричиняє виникнення або прогресування стрикту=
р.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Пацієнти літнього віку</span><=
/h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>Ча=
стота
розвитку серйозних інфекцій у пацієнтів віком від 65 років, які отримували =
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-=
bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, </span=
><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-font-style:italic'>(3,7&nbsp;%), вища, ніж у молодших пацієнтів=
 (1,5
%). Деякі випадки були летальними. </span><span lang=3DUK style=3D'mso-bidi=
-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>При
лікуванні пацієнтів літнього віку особливу увагу слід приділити оцінці ризи=
ку
виникнення інфекцій.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Діти</span></h4>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>Д=
ив.
підрозділ «</span></i><span lang=3DUK style=3D'color:windowtext;mso-ansi-la=
nguage:
UK'>Вакцинація</span><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>»=
 вище.</span></i><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'><o:p></o:p></span=
></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Допоміжні речовини із відомим =
ефектом</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
mso-ansi-language:UK'>Цей лікарський засіб містить 0,2 мг полісобату-80 на
кожні 20 мг дози. Полісорбати можуть спричиняти алергічні реакції.<o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Застосування у період вагітнос=
ті або
годування груддю.</span></h3>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Жінки
репродуктивного віку<o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
mso-ansi-language:UK'>Для запобігання вагітності жінки репродуктивного віку
повинні користуватися надійними методами контрацепції під час лікування та
протягом щонайменше п’яти місяців після введення останньої дози препарату <=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>®</sup></span><span lang=3DUK style=3D'color:windowtext;mso-=
ansi-language:
UK'>.<o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Вагітність<o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>В результаті проспективного анал=
ізу
даних щодо застосування адалімумабу під час вагітності (приблизно 2100 випа=
дків
вагітностей, які завершилися народженням живих дітей з відомими наслідками,=
 у
тому числі понад 1500 випадків застосування препарату у першому триместрі) =
не
виявлено збільшення частоти виникнення вад розвитку у новонароджених.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>В
проспективний когортний реєстр було включено 257 жінок з РА або ХК, які
отримували адалімумаб як мінімум протягом першого триместру, та 120 жінок з=
 РА
або ХК, які не отримували адалімумаб. </span><span lang=3DUK style=3D'color=
:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Первинною кінцевою точкою була
частота розвитку значних вроджених вад у новонароджених. Частота випадків
вагітностей, які завершилися народженням принаймні однієї живої дитини зі
значною вродженою вадою, становила 6 з 69 (8,7 %) в групі жінок з РА, які
отримували адалімумаб, та 5 з 74 (6,8 %) – в групі жінок з РА, які не
застосовували препарат (нескориговане відношення шансів [ВШ] – 1,31, 95 %
довірчий інтервал [ДІ] – 0,38–4,52). В групі жінок з ХК, які отримували
адалімумаб, частота таких випадків становила 16 з 152 (10,5 %), а в групі ж=
інок
з ХК, які не застосовували препарат, відповідно 3 з 32 (9,4 %) (нескоригова=
не
ВШ – 1,14, 95 % ДІ – 0,31–4,16). В об’єднаній групі жінок з РА та ХК
скориговане ВШ (з поправкою на відмінності на вихідному рівні) становило 1,=
10
(95 % ДІ – 0,45–2,73). Між жінками, які застосовували та не застосовували
адалімумаб, не було виявлено чітко виражених відмінностей щодо вторинних
кінцевих точок у вигляді спонтанних абортів, незначних вроджених вад,
передчасних пологів, маси тіла та зросту новонароджених і серйозних або
опортуністичних інфекцій, а також не було зареєстровано випадків
мертвонародження або розвитку злоякісних пухлин. На інтерпретацію даних мог=
ли
впливати методологічні обмеження дослідження, у тому числі малий об’єм вибі=
рки
та нерандомізований дизайн дослідження.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>В експериментальному дослідженні
токсичності на мавпах не було виявлено ознак токсичної дії на материнський
організм, а також ембріотоксичної та тератогенної дії. Доклінічні дані щодо
постнатальної токсичності адалімумабу відсутні.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Оскільки адалімумаб інгібує
ФНП-&#945;, його застосування під час вагітності може порушити нормальні ім=
унні
реакції у новонародженого. Вагітним жінкам слід застосовувати адалімумаб ли=
ше у
разі очевидної необхідності.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>Ад=
алімумаб
може проникати через плаценту в сироватку крові новонароджених, матері яких=
 отримували
адалімумаб під час вагітності. Тому у таких новонароджених може бути підвищ=
ений
ризик інфікування. </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Застосування жи=
вих
вакцин (наприклад вакцини БЦЖ)<span style=3D'mso-spacerun:yes'> 
</span>немовлятам, що піддавалися впливу адалімумабу внутрішньоутробно, не
рекомендується протягом 5 місяців після останньої ін'єкції адалімумабу мате=
рі у
період вагітності.<o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Годування
груддю<span style=3D'mso-spacerun:yes'>  </span><o:p></o:p></span></i></h5>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;background:white;mso-ansi-language:UK'>Обмежені
опубліковані дані свідчать про те, що адалімумаб екскретується у грудне мол=
око
у дуже низьких концентраціях – від 0,1 % до 1 % рівня у сироватці матері. З=
 огляду
на те, що білки імуноглобуліну G піддаються в кишечнику протеолізу і мають
низьку біодоступність, системний вплив адалімумабу на немовлят, які знаходя=
ться
на грудному вигодовуванні, малоймовірний. </span><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Отже, препарат </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Хуміра<sup>®</sup></span><span lang=3DUK style=3D'color:windowtext;mso-=
ansi-language:
UK'> можна застосовувати в період годування груддю.<o:p></o:p></span></p>

<h5 style=3D'margin-top:0cm'><i style=3D'mso-bidi-font-style:normal'><span =
lang=3DUK>Фертильність<o:p></o:p></span></i></h5>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'>Доклінічні дані щодо впливу адалімумабу на фертильність відсутні.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Здатність впливати на швидкість
реакції при керуванні автотранспортом або іншими механізмами.</span></h3>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bidi-fon=
t-size:
12.0pt;color:windowtext;mso-bidi-font-weight:bold'>Хуміра<sup>® </sup></spa=
n><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>може мати незначний вплив на швидкість реакції при керуванні
автотранспортом або іншими механізмами. Застосування лікарського засобу Хум=
іра<sup>®
</sup>може спричинити виникнення вертиго та порушення гостроти зору (див.
розділ «Побічні реакції»).<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK>Спосіб застосування та дози.</=
span></h3>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;background:white'><a
name=3D"_Hlk16087007"><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;co=
lor:windowtext;
mso-ansi-language:UK'>Терапію лікарським засобом Хуміра<sup>® </sup>повинен
призначати лікар, який має досвід у діагностуванні та терапії захворювань, =
при
яких показана Хуміра<sup>®</sup>. Офтальмологам рекомендовано
проконсультуватися з відповідним спеціалістом перед тим, як призначати тера=
пію
лікарським засобом Хуміра<sup>®</sup>. Лікарський засіб Хуміра<sup>® </sup>=
можна
вводити самостійно тільки у разі, якщо пацієнт або батьки дитини, якій
призначена терапія лікарським засобом Хуміра<sup>®</sup>, пройшли відповідн=
ий
інструктаж у лікаря щодо техніки введення ін’єкції та лікар підтвердив, що =
це
можливо. Додатково необхідно ознайомитись з інформацією щодо самостійного
введення, яка міститься в цій інструкції. Пацієнт або батьки дитини, якій
призначена терапія лікарським засобом Хуміра<sup>®</sup>, мають ознайомитис=
я з
інформаційною карткою. Під час лікування лікарським засобом Хуміра<sup>® </=
sup>інші
супутні види терапії (наприклад терапію кортикостероїдами та/або
імуномодулюючими препаратами) потрібно переглянути.<o:p></o:p></span></a></=
p>

<h4 style=3D'margin-top:0cm'><span style=3D'mso-bookmark:_Hlk16087007'><span
lang=3DUK>Ювенільний ревматоїдний (ідіопатичний) артрит (ЮРА)</span></span>=
</h4>

<h4 style=3D'margin-top:0cm'><span style=3D'mso-bookmark:_Hlk16087007'><span
lang=3DUK>Поліартикулярний ювенільний ревматоїдний (ідіопатичний) артрит</s=
pan></span></h4>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Рекомендована доза </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для дітей віком=
 від
2 років з поліартикулярною формою ЮРА залежить від маси тіла (таблиця 1). <=
/span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup>=
</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>застосовують 1 =
раз
на 2 тижні підшкірно. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Таблиця 1. Дозування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для пацієнтів з
поліартикулярною формою ЮРА<o:p></o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D328 valign=3Dtop style=3D'width:246.3pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Маса т=
іла<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D328 valign=3Dtop style=3D'width:246.35pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Доза<o=
:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D328 valign=3Dtop style=3D'width:246.3pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK'>Від 10 кг до 30 кг</span></=
span><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D328 valign=3Dtop style=3D'width:246.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>20 мг 1
  раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D328 valign=3Dtop style=3D'width:246.3pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>30 кг =
та
  більше<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D328 valign=3Dtop style=3D'width:246.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>40 мг 1
  раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
</table>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>Клінічна відповідь, згідно з існуючими даними, зазвич=
ай
досягається протягом 12 тижнів лікування. Слід переглянути необхідність
продовження терапії для пацієнтів, у яких протягом вказаного терміну не
спостерігається відповіді на лікування. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Лікарський засіб Хуміра<sup>® </sup></span></span><span style=3D'mso-bo=
okmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK;mso-bidi-language:BO'>не застосовують за цим показанням
дітям віком до 2 років.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Лікарський засіб Хуміра</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><sup><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>®</span></sup></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> доступний в ін=
ших
дозуваннях залежно від індивідуальних потреб в лікуванні.<o:p></o:p></span>=
</span></p>

<h4 style=3D'margin-top:0cm'><span style=3D'mso-bookmark:_Hlk16087007'><span
lang=3DUK>Ентезит-асоційований артрит</span></span></h4>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Рекомендована доза </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для дітей віком=
 від
6 років залежить від маси тіла (таблиця 2). </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup>=
</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>застосовують 1 =
раз
на 2 тижні підшкірно. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Таблиця 2. Дозування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для пацієнтів з
ентезит-асоційованим артритом<o:p></o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D321 valign=3Dtop style=3D'width:240.75pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Маса т=
іла<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D321 valign=3Dtop style=3D'width:240.6pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Доза<o=
:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D321 valign=3Dtop style=3D'width:240.75pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK'>Від 15 кг до 30 кг</span></=
span><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D321 valign=3Dtop style=3D'width:240.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>20 мг 1
  раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D321 valign=3Dtop style=3D'width:240.75pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>30 кг =
та
  більше<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D321 valign=3Dtop style=3D'width:240.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>40 мг 1
  раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Застосування </span></span><span style=3D'mso-book=
mark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span></span><=
span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>дітям віком до 6
років з ентезит-асоційованим артритом не вивчалось. Лікарський засіб Хуміра=
</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><sup><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>®</span></sup></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> доступний в ін=
ших
дозуваннях залежно від індивідуальних потреб в лікуванні.<o:p></o:p></span>=
</span></p>

<h4 style=3D'margin-top:0cm'><span style=3D'mso-bookmark:_Hlk16087007'><span
lang=3DUK>Хвороба Крона у дітей</span></span></h4>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Рекомендована доза </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для<span
style=3D'mso-spacerun:yes'>  </span>пацієнтів віком від 6 до 17 років з хво=
робою
Крона залежить від маси тіла (таблиця 3). </span></span><span style=3D'mso-=
bookmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup></span></span><sp=
an
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>застосовують
підшкірно. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Таблиця 3. Дозування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для дітей із
хворобою Крона<o:p></o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D84 valign=3Dtop style=3D'width:62.75pt;border:solid windowtex=
t 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>Маса тіла<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D390 valign=3Dtop style=3D'width:292.5pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>Індукційна доза<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D168 valign=3Dtop style=3D'width:126.1pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>Підтримуюча терапія,<span style=3D'mso-spacerun:yes=
'> 
  </span>починаючи з тижня 4<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D84 valign=3Dtop style=3D'width:62.75pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>&lt; 40 кг<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D390 valign=3Dtop style=3D'width:292.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>40 мг на тижні 0 та 20 мг на тижні 2<o:p></o:p></sp=
an></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>Якщо існує потреба в більш швидкій відповіді на
  терапію, можна використовувати таку схему:<o:p></o:p></span></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>80 мг на тижні 0 та 40 мг на тижні 2. Але слід
  враховувати, що ризик побічних явищ при застосуванні більш високої
  індукційної дози зростає.<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D168 valign=3Dtop style=3D'width:126.1pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>20 мг 1 раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D84 valign=3Dtop style=3D'width:62.75pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>&#8805; 40 кг<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D390 valign=3Dtop style=3D'width:292.5pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>80 мг на тижні 0 та 40 мг на тижні 2<o:p></o:p></sp=
an></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>Якщо існує потреба в більш швидкій відповіді на
  терапію, можна використовувати таку схему:<o:p></o:p></span></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>160 мг на тижні 0 та 80 мг на тижні 2. Але слід
  враховувати, що ризик побічних явищ при застосуванні більш високої
  індукційної дози зростає.<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D168 valign=3Dtop style=3D'width:126.1pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
  mso-bidi-language:BO'>40 мг 1 раз на 2 тижні<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Для пацієнтів з недостатньою відповіддю може бути
доцільним збільшення частоти застосувань </span></span><span style=3D'mso-b=
ookmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>®</sup></span></span><s=
pan
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>:<o:p></o:p></s=
pan></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'text-indent:-18.0pt;mso-list:=
l6 level1 lfo5'><span
style=3D'mso-bookmark:_Hlk16087007'><![if !supportLists]><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'><span style=3D'mso-list:Ignore'>·<span style=3D'font:=
7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>пацієнтам з мас=
ою
тіла &lt; 40 кг: 20 мг 1 раз на тиждень;<o:p></o:p></span></span></p>

<p class=3DMsoListParagraphCxSpLast style=3D'text-indent:-18.0pt;mso-list:l=
6 level1 lfo5'><span
style=3D'mso-bookmark:_Hlk16087007'><![if !supportLists]><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'><span style=3D'mso-list:Ignore'>·<span style=3D'font:=
7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>пацієнтам з мас=
ою тіла
&#8805; 40 кг: 40 мг 1 раз на тиждень або 80 мг 1 раз на 2 тижні.<o:p></o:p=
></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>Слід ретельно переглянути </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>необхідність продовження терапії для
пацієнтів, у яких протягом 12 тижнів не спостерігається клінічної відповіді=
.</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o:p></sp=
an></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Лікарський засіб Хуміра<sup>® </sup></span></span><span style=3D'mso-bo=
okmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK;mso-bidi-language:BO'>не застосовують за цим показанням
дітям віком до 6 років.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Лікарський засіб Хуміра</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><sup><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>®</span></sup></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> доступний в ін=
ших
дозуваннях залежно від індивідуальних потреб в лікуванні.<o:p></o:p></span>=
</span></p>

<h4 style=3D'margin-top:0cm'><span style=3D'mso-bookmark:_Hlk16087007'><span
lang=3DUK>Бляшковий псоріаз у дітей</span></span></h4>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Рекомендована доза </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для пацієнтів в=
іком
від 4 до 17 років з бляшковим псоріазом залежить від маси тіла (таблиця 4).=
 </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup>=
</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>застосовують
підшкірно.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>Таблиця 4. Дозування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для дітей з
бляшковим псоріазом<o:p></o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D247 valign=3Dtop style=3D'width:185.4pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Маса т=
іла <o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D395 valign=3Dtop style=3D'width:295.95pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Доза<o=
:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D247 valign=3Dtop style=3D'width:185.4pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK'>Від 15 кг до 30 кг</span></=
span><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p><=
/o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D395 valign=3Dtop style=3D'width:295.95pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Початк=
ова
  доза становить 20 мг на тижні 0, <o:p></o:p></span></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>потім =
20
  мг 1 раз на 2 тижні, починаючи з тижня 1<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D247 valign=3Dtop style=3D'width:185.4pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>30 кг =
та
  більше<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D395 valign=3Dtop style=3D'width:295.95pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Початк=
ова
  доза становить 40 мг на тижні 0, <o:p></o:p></span></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>потім =
40
  мг 1 раз на 2 тижні, починаючи з тижня 1<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Слід ретельно переглянути </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>необхідність продовження терапії для
пацієнтів, у яких протягом 16 тижнів не спостерігається клінічної відповіді=
. </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Якщо призначено
повторну терапію </span></span><span style=3D'mso-bookmark:_Hlk16087007'><s=
pan
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарським засобом Хуміра<sup>®</sup></span></span><span style=3D'mso-b=
ookmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK;mso-bidi-language:BO'>, необхідно дотримуватись схеми
лікування, зазначеної вище. Безпека застосування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>дітям з бляшков=
им
псоріазом вивчалась в середньому протягом 13 місяців.<o:p></o:p></span></sp=
an></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Застосування </span></span><span style=3D'mso-book=
mark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span></span><=
span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>дітям віком до 4
років з бляшковим псоріазом не вивчалось.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Лікарський засіб Хуміра</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><sup><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>®</span></sup></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> доступний в ін=
ших
дозуваннях залежно від індивідуальних потреб в лікуванні.</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span class=3D4><span lang=3DUK style=
=3D'color:
windowtext;mso-ansi-language:UK'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span class=
=3D4><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'>Увеїт у дітей<o:p=
></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087007'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>Рекомендована доза </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>для дітей віком=
 від
2 років з хронічним неінфекційним увеїтом залежить від маси тіла (таблиця 5=
)</span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>. Лікарський засіб Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>застосовують
підшкірно. Немає даних щодо застосування </span></span><span style=3D'mso-b=
ookmark:
_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </sup></span></span><=
span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>без супутньої
терапії метотрексатом дітям з увеїтом.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087007'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>Таблиця 5. Дозування </span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарського засобу Хуміра<sup>® </su=
p></span></span><span
style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-=
size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>дітям з увеїтом=
<o:p></o:p></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D274 valign=3Dtop style=3D'width:205.75pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Маса т=
іла<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D367 valign=3Dtop style=3D'width:275.6pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Доза<o=
:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D274 valign=3Dtop style=3D'width:205.75pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>До<span
  style=3D'mso-spacerun:yes'>  </span></span></span><span style=3D'mso-book=
mark:
  _Hlk16087007'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wi=
ndowtext;
  mso-ansi-language:UK'>30 кг</span></span><span style=3D'mso-bookmark:_Hlk=
16087007'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D367 valign=3Dtop style=3D'width:275.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>20 мг 1
  раз на 2 тижні в комбінації з метотрексатом<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D274 valign=3Dtop style=3D'width:205.75pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>30 кг =
та
  більше<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
  <td width=3D367 valign=3Dtop style=3D'width:275.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk16087007'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>40 мг 1
  раз на 2 тижні в комбінації з метотрексатом<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk16087007'></span>
 </tr>
</table>

<span style=3D'mso-bookmark:_Hlk16087007'></span>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>®=
 </sup>можна
застосовувати в комбінації з метотрексатом або іншими небіологічними імуном=
одулюючими
препаратами відповідно до клінічного досвіду.<span style=3D'mso-spacerun:ye=
s'> 
</span></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Початкова навантажувальна доза <=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>® </sup></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>становить 40 мг для пацієнтів з масою тіла до 30 кг і=
 80
мг<span style=3D'mso-spacerun:yes'>  </span>для пацієнтів, маса тіла яких 3=
0 кг і
більше; її можна ввести за тиждень до початку підтримуючої терапії. Немає
клінічних даних щодо введення початкової навантажувальної дози </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>® </sup></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>дітям віком до 6 років. Застосовування </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>® </sup></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>дітям віком до 2 років за даним показанням не
обґрунтоване.</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;colo=
r:windowtext;
mso-ansi-language:UK'> </span><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Рекомендується
щорічно оцінювати користь та ризик довготривалого лікування. Лікарський зас=
іб
Хуміра</span><sup><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:=
windowtext;
mso-ansi-language:UK'>®</span></sup><span lang=3DUK style=3D'mso-bidi-font-=
size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'> доступн=
ий в
інших дозуваннях залежно від індивідуальних потреб в лікуванні.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><u><span lang=
=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Пацієнти літнього віку <o:p=
></o:p></span></u></i></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Корекція дози для цієї групи пацієнтів не потрібна.<o=
:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Порушення функції печінки та/а=
бо нирок</span></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Застосування </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарського
засобу Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>таким пацієнтам=
 не
досліджувалось, тому рекомендації щодо зміни дози відсутні. <o:p></o:p></sp=
an></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Введення </span></h4>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>необхідно застосовувати під наглядом лікаря. За
рекомендацією лікаря пацієнти або їхні батьки/ близькі люди можуть самостій=
но
вводити препарат після відповідного навчання техніці підшкірного введення.<=
o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D657 valign=3Dtop style=3D'width:492.65pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><b style=3D'mso-bidi-f=
ont-weight:
  normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowte=
xt;
  mso-ansi-language:UK'>ІНСТРУКЦІЯ ЩОДО САМОСТІЙНОГО ВВЕДЕННЯ </span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
  12.0pt;mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-language:
  UK;mso-fareast-language:EN-US'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>Ця
  інструкція пояснює, як самостійно вводити лікарський засіб Хуміра<sup>®</=
sup>.
  Будь ласка, уважно прочитайте її та виконуйте крок за кроком. </span><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:Cali=
bri;
  color:windowtext;mso-ansi-language:UK;mso-fareast-language:EN-US'><o:p></=
o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>Ваш
  лікар або медична сестра пояснять Вам техніку самостійного виконання
  підшкірної ін’єкції. <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>Не
  намагайтеся виконати ін’єкцію своїй дитині доти, доки Ви не будете впевне=
ні у
  правильності приготування та виконання ін’єкції. <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>Після
  відповідного навчання Ви можете виконувати ін’єкції своїй дитині самостій=
но
  або за допомогою членів родини або друзів.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>Використовуйте
  кожен попередньо наповнений шприц тільки для однієї ін’єкції.<o:p></o:p><=
/span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:12.0pt'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
><span
  style=3D'mso-spacerun:yes'>                                 </span>Поршен=
ь<span
  style=3D'mso-spacerun:yes'>                      </span>Упор для пальців<=
span
  style=3D'mso-spacerun:yes'>          </span>Ковпачок голки<o:p></o:p></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:12.0pt;text-al=
ign:center'><span
  lang=3DEN-US style=3D'mso-bidi-font-size:10.0pt;color:windowtext;mso-ansi=
-language:
  EN-US;mso-fareast-language:EN-US;mso-no-proof:yes'><v:shapetype id=3D"_x0=
000_t75"
   coordsize=3D"21600,21600" o:spt=3D"75" o:preferrelative=3D"t" path=3D"m@=
4@5l@4@11@9@11@9@5xe"
   filled=3D"f" stroked=3D"f">
   <v:stroke joinstyle=3D"miter"/>
   <v:formulas>
    <v:f eqn=3D"if lineDrawn pixelLineWidth 0"/>
    <v:f eqn=3D"sum @0 1 0"/>
    <v:f eqn=3D"sum 0 0 @1"/>
    <v:f eqn=3D"prod @2 1 2"/>
    <v:f eqn=3D"prod @3 21600 pixelWidth"/>
    <v:f eqn=3D"prod @3 21600 pixelHeight"/>
    <v:f eqn=3D"sum @0 0 1"/>
    <v:f eqn=3D"prod @6 1 2"/>
    <v:f eqn=3D"prod @7 21600 pixelWidth"/>
    <v:f eqn=3D"sum @8 21600 0"/>
    <v:f eqn=3D"prod @7 21600 pixelHeight"/>
    <v:f eqn=3D"sum @10 21600 0"/>
   </v:formulas>
   <v:path o:extrusionok=3D"f" gradientshapeok=3D"t" o:connecttype=3D"rect"=
/>
   <o:lock v:ext=3D"edit" aspectratio=3D"t"/>
  </v:shapetype><v:shape id=3D"Picture_x0020_34" o:spid=3D"_x0000_i1025" ty=
pe=3D"#_x0000_t75"
   style=3D'width:264.75pt;height:116.25pt;visibility:visible'>
   <v:imagedata src=3D"UA168180101_C4B6.files/image001.jpg" o:title=3D""/>
  </v:shape></span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color=
:windowtext;
  mso-ansi-language:UK'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><b style=3D'mso-bidi-f=
ont-weight:
  normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowte=
xt;
  mso-ansi-language:UK'>Не використовуйте шприц та повідомте Вашого лікаря
  якщо:<o:p></o:p></span></b></p>
  <p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:6.0pt;mso-add=
-space:
  auto;text-indent:-18.0pt;mso-list:l2 level1 lfo7'><![if !supportLists]><s=
pan
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-farea=
st-font-family:
  Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK'=
><span
  style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
  color:windowtext;mso-ansi-language:UK'>якщо розчин помутнів, змінив колір=
 або
  містить сторонні частинки<o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
  auto;text-indent:-18.0pt;mso-list:l2 level1 lfo7'><![if !supportLists]><s=
pan
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-farea=
st-font-family:
  Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK'=
><span
  style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
  color:windowtext;mso-ansi-language:UK'>якщо прострочений термін придатнос=
ті <o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
  auto;text-indent:-18.0pt;mso-list:l2 level1 lfo7'><![if !supportLists]><s=
pan
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-farea=
st-font-family:
  Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK'=
><span
  style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
  color:windowtext;mso-ansi-language:UK'>якщо рідину заморожували або залиш=
али
  під прямими сонячними променями<o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:6.0pt;mso-add-=
space:
  auto;text-indent:-18.0pt;mso-list:l2 level1 lfo7'><![if !supportLists]><s=
pan
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-farea=
st-font-family:
  Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:UK'=
><span
  style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
  color:windowtext;mso-ansi-language:UK'>якщо шприц впав чи пошкоджений<o:p=
></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><b style=3D'mso-bidi-f=
ont-weight:
  normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowte=
xt;
  mso-ansi-language:UK'>Не знімайте ковпачок аж до самої ін’єкції. Зберігай=
те <span
  style=3D'mso-bidi-font-weight:bold'>лікарський засіб Хуміра<sup>®</sup></=
span></span></b><sup><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK'> </span></sup><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
  style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'=
>у
  недоступному для дітей місці.<o:p></o:p></span></b></p>
  <table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
   style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windo=
wtext .5pt;
   mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-ins=
ideh:
   .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
   <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
    <td width=3D630 colspan=3D2 valign=3Dtop style=3D'width:472.65pt;border=
:solid windowtext 1.0pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><b style=3D'mso-bidi=
-font-weight:
    normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:window=
text;
    mso-ansi-language:UK'>КРОК 1<o:p></o:p></span></b></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;background:white'><sp=
an
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Витягніть лікарський засіб Хуміра<sup>® </sup>з холодильника.<o:p><=
/o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Залиште
    лікарський засіб Хуміра<sup>® </sup>при кімнатній температурі на 15–30
    хвилин перед виконанням ін’єкції.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:6.0pt;mso-a=
dd-space:
    auto;text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]>=
<span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не знімайте</span></b><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
    color:windowtext;mso-ansi-language:UK'> ковпачок з голки, доки Хуміра не
    досягне кімнатної температури.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
    auto;text-indent:-18.0pt;mso-list:l8 level1 lfo8'><![if !supportLists]>=
<span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не нагрівайте</span></b><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
    color:windowtext;mso-ansi-language:UK'> лікарський засіб Хуміра<sup>® <=
/sup>будь-яким
    іншим способом (наприклад, в мікрохвильовій печі або у гарячій воді).<o=
:p></o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:1'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    2<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-spacerun:yes'>       </span>Шприц<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DEN-US style=3D'mso-bidi-font-size:10.=
0pt;
    color:windowtext;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
    mso-no-proof:yes'><v:shape id=3D"Picture_x0020_35" o:spid=3D"_x0000_i10=
26"
     type=3D"#_x0000_t75" style=3D'width:168.75pt;height:156pt;visibility:v=
isible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image002.jpg" o:title=3D""/>
    </v:shape></span><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-spacerun:yes'>        </span>Серветка<o:p></o:p></span></b=
></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Подивіться
    на строк придатності лікарського засобу. <b style=3D'mso-bidi-font-weig=
ht:
    normal'>Не застосовуйте</b> препарат із терміном придатності, що минув.=
<o:p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Викладіть
    такі предмети на чисту і рівну поверхню:</span><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:Calibri;
    color:windowtext;mso-ansi-language:UK;mso-fareast-language:EN-US'><o:p>=
</o:p></span></p>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:6.0pt;mso-a=
dd-space:
    auto;text-indent:-18.0pt;mso-list:l1 level1 lfo9;background:white'><![i=
f !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>один шприц для ін’єкції з=
 лікарським
    засобом Хуміра<sup>®</sup><o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
    auto;text-indent:-18.0pt;mso-list:l1 level1 lfo9'><![if !supportLists]>=
<span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>одну спиртову серветку<o:=
p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Добре
    помийте та висушіть руки.</span><span lang=3DUK style=3D'mso-bidi-font-=
size:
    12.0pt;mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-langua=
ge:
    UK;mso-fareast-language:EN-US'><o:p></o:p></span></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:2'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    3<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
    color:windowtext;mso-ansi-language:UK'>місця для ін’єкцій<b
    style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>
    <p class=3DMsoNormal><span lang=3DEN-US style=3D'mso-bidi-font-size:10.=
0pt;
    color:windowtext;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
    mso-no-proof:yes'><v:shape id=3D"Picture_x0020_86" o:spid=3D"_x0000_i10=
27"
     type=3D"#_x0000_t75" alt=3D"STEP3_grey" style=3D'width:179.25pt;height=
:187.5pt;
     visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image003.jpg" o:title=3D"ST=
EP3_grey"/>
    </v:shape></span><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
    color:windowtext;mso-ansi-language:UK'><span style=3D'mso-spacerun:yes'=
> 
    </span>місця для ін’єкцій<o:p></o:p></span></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:2.0pt;margin-r=
ight:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Виберіть
    місця для ін’єкції Вашій дитині:<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:6.0pt;mso-=
add-space:
    auto;text-indent:-18.0pt;mso-list:l3 level1 lfo10'><![if !supportLists]=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>передня частина стегон аб=
о<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:6.0pt;mso-=
add-space:
    auto;text-indent:-18.0pt;mso-list:l3 level1 lfo10'><![if !supportLists]=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-langua=
ge:
    UK'>живіт на відстані не менше 5 см від пупка</span><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast align=3Dleft style=3D'margin-bottom=
:6.0pt;
    mso-add-space:auto;text-align:left;text-indent:-18.0pt;mso-list:l3 leve=
l1 lfo10'><![if !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>кожна нова ін’єкція повин=
на
    бути зроблена на відстані як мінімум 3 см від місця попереднього введен=
ня<o:p></o:p></span></p>
    <p class=3DMsoNormal align=3Dleft style=3D'margin-bottom:6.0pt;text-ali=
gn:left'><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Протріть спиртовою серветкою круговими рухами вибране Вами місце для
    ін’єкції.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:6.0pt;mso-a=
dd-space:
    auto;text-indent:-18.0pt;mso-list:l7 level1 lfo11'><![if !supportLists]=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не вводьте</span></b><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
    color:windowtext;mso-ansi-language:UK'> лікарський засіб через одяг<o:p=
></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
    auto;text-indent:-18.0pt;mso-list:l7 level1 lfo11'><![if !supportLists]=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не вводьте</span></b><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
    color:windowtext;mso-ansi-language:UK'> лікарський засіб в ділянку шкір=
и,
    яка є чутливою, де утворився синець, почервоніння, яка є твердою чи має
    шрами, розтяжки, або у ділянки<span style=3D'mso-spacerun:yes'>  </span=
>з
    псоріатичними бляшками<o:p></o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:3'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    4<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DEN-US
    style=3D'mso-bidi-font-size:10.0pt;color:windowtext;mso-ansi-language:E=
N-US;
    mso-fareast-language:EN-US;mso-no-proof:yes'><v:shape id=3D"Picture_x00=
20_36"
     o:spid=3D"_x0000_i1028" type=3D"#_x0000_t75" style=3D'width:158.25pt;h=
eight:123pt;
     visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image004.jpg" o:title=3D""/>
    </v:shape></span></b><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:2.0pt;margin-r=
ight:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-top:2.0pt;margin-ri=
ght:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Тримайте
    попередньо наповнений шприц в одній руці.<o:p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;tab-stops:36.0pt;mso-=
layout-grid-align:
    none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
    mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-language:UK'>=
Перевірте
    рідину в шприці.</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0=
pt;
    mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-language:UK;
    mso-fareast-language:EN-US'><o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:6.0pt;mso-a=
dd-space:
    auto;text-indent:-18.0pt;mso-list:l13 level1 lfo12'><![if !supportLists=
]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>Переконайтесь, що рідина
    чиста та безбарвна<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:6.0pt;mso-=
add-space:
    auto;text-indent:-18.0pt;mso-list:l13 level1 lfo12'><![if !supportLists=
]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не використовуйте</span></b><span lang=3DUK style=3D'mso-bidi-font-=
size:
    12.0pt;color:windowtext;mso-ansi-language:UK'> шприц, якщо розчин помут=
нів
    або містить сторонні частинки<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:6.0pt;mso-ad=
d-space:
    auto;text-indent:-18.0pt;mso-list:l13 level1 lfo12'><![if !supportLists=
]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не використовуйте</span></b><span lang=3DUK style=3D'mso-bidi-font-=
size:
    12.0pt;color:windowtext;mso-ansi-language:UK'> шприц, якщо він впав чи
    пошкоджений<o:p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Обережно
    зніміть ковпачок з голки шприца іншою рукою. Не надягайте знову ковпачо=
к на
    голку.<o:p></o:p></span></p>
    <p class=3DMsoListParagraph style=3D'margin-bottom:6.0pt;mso-add-space:=
auto;
    text-indent:-18.0pt;mso-list:l9 level1 lfo13'><![if !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:Symbol;mso-far=
east-font-family:
    Symbol;mso-bidi-font-family:Symbol;color:windowtext;mso-ansi-language:U=
K'><span
    style=3D'mso-list:Ignore'>·<span style=3D'font:7.0pt "Times New Roman"'=
>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Не торкайтеся</span></b><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
    color:windowtext;mso-ansi-language:UK'> пальцями голки і уникайте конта=
кту
    голки з будь-якими предметами <o:p></o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:4'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    5<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DEN-US style=3D'mso-bidi-font-size:10.=
0pt;
    color:windowtext;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
    mso-no-proof:yes'><v:shape id=3D"Picture_x0020_88" o:spid=3D"_x0000_i10=
29"
     type=3D"#_x0000_t75" alt=3D"STEP_5_SYRINGE_IFU_FILLING_grey" style=3D'=
width:156.75pt;
     height:155.25pt;visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image005.jpg" o:title=3D"ST=
EP_5_SYRINGE_IFU_FILLING_grey"/>
    </v:shape></span><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:2.0pt;margin-r=
ight:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Тримайте<span
    style=3D'mso-spacerun:yes'>  </span>шприц голкою вверх однією рукою на =
рівні
    очей, так щоб Ви могли бачити повітря у шприці.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>Повільно
    натискайте поршень, щоб випустити повітря через голку.<o:p></o:p></span=
></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:Calibri;
    color:windowtext;mso-ansi-language:UK'>Це нормально, побачити краплю рі=
дини
    на кінці голки.</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
    color:windowtext;mso-ansi-language:UK'><o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-top:2.0pt;margin-ri=
ght:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:5'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    6<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DEN-US style=3D'mso-bidi-font-size:10.=
0pt;
    color:windowtext;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
    mso-no-proof:yes'><v:shape id=3D"Picture_x0020_89" o:spid=3D"_x0000_i10=
30"
     type=3D"#_x0000_t75" alt=3D"STEP_6_SYRINGE_IFU_PRE-INJECTION_grey" sty=
le=3D'width:177pt;
     height:168pt;visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image006.jpg" o:title=3D"ST=
EP_6_SYRINGE_IFU_PRE-INJECTION_grey"/>
    </v:shape></span><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;tab-stops:36.0pt;mso-=
layout-grid-align:
    none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
    color:windowtext;mso-ansi-language:UK'>Тримайте корпус шприца однією ру=
кою
    між великим і вказівним пальцями так, ніби тримаєте олівець.<o:p></o:p>=
</span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;tab-stops:36.0pt;mso-=
layout-grid-align:
    none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
    color:windowtext;mso-ansi-language:UK'>Іншою рукою обережно візьміть
    ділянку очищеної шкіри у складку і міцно утримуйте її.<o:p></o:p></span=
></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;tab-stops:36.0pt;mso-=
layout-grid-align:
    none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:1=
2.0pt;
    color:windowtext;mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoListParagraph style=3D'margin-top:2.0pt;margin-right:0cm;
    margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:6'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    7<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><span lang=3DEN-US style=3D'mso-bidi-font-size:10.=
0pt;
    color:windowtext;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
    mso-no-proof:yes'><v:shape id=3D"Picture_x0020_90" o:spid=3D"_x0000_i10=
31"
     type=3D"#_x0000_t75" alt=3D"STEP_7_SYRINGE_IFU_ABDOMEN-THIGH_grey" sty=
le=3D'width:173.25pt;
     height:210.75pt;visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image007.jpg" o:title=3D"ST=
EP_7_SYRINGE_IFU_ABDOMEN-THIGH_grey"/>
    </v:shape></span><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal align=3Dleft style=3D'margin-bottom:6.0pt;text-ali=
gn:left'><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Одним швидким коротким рухом введіть голку повністю в шкіру </span>=
<span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:Ca=
libri;
    color:windowtext;mso-ansi-language:UK'>під кутом приблизно 45 градусів<=
/span><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>, після чого відпустіть шкіру.<o:p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;page-break-after:avoi=
d;
    tab-stops:36.0pt'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
    color:windowtext;mso-ansi-language:UK'>Повільно натискайте на поршень
    шприца до кінця, доки вся рідина не буде введена.</span><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K;
    mso-fareast-language:EN-US'><o:p></o:p></span></p>
    <p class=3DMsoListParagraph style=3D'margin-top:2.0pt;margin-right:0cm;
    margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:7'>
    <td width=3D253 valign=3Dtop style=3D'width:189.85pt;border:solid windo=
wtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    8<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DEN-US
    style=3D'mso-bidi-font-size:10.0pt;color:windowtext;mso-ansi-language:E=
N-US;
    mso-fareast-language:EN-US;mso-no-proof:yes'><v:shape id=3D"Picture_x00=
20_37"
     o:spid=3D"_x0000_i1032" type=3D"#_x0000_t75" style=3D'width:156pt;heig=
ht:165pt;
     visibility:visible'>
     <v:imagedata src=3D"UA168180101_C4B6.files/image008.jpg" o:title=3D""/>
    </v:shape></span></b><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p></o:p></span></b></p>
    </td>
    <td width=3D377 valign=3Dtop style=3D'width:282.8pt;border-top:none;bor=
der-left:
    none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext=
 1.0pt;
    mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid wind=
owtext .5pt;
    mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal align=3Dleft style=3D'margin-bottom:6.0pt;text-ali=
gn:left'><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'><o:p>&nbsp;</o:p></span></p>
    <p class=3DMsoNormal align=3Dleft style=3D'margin-bottom:6.0pt;text-ali=
gn:left'><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'>Коли ін’єкцію завершено, повільно витягніть голку зі шкіри під тим
    самим кутом, що і вводили.<o:p></o:p></span></p>
    <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;page-break-after:avoi=
d;
    tab-stops:36.0pt'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
    color:windowtext;mso-ansi-language:UK'>Притисніть ватною кулькою чи
    марлевою подушечкою місце ін’єкції на 10 секунд.</span><span lang=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K;
    mso-fareast-language:EN-US'><o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:2.0pt;margin-r=
ight:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><b
    style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi=
-font-size:
    12.0pt;color:windowtext;mso-ansi-language:UK'>Не тріть</span></b><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-=
language:
    UK'> шкіру у місці ін’єкції.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'margin-top:2.0pt;margin-=
right:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>У
    місці ін’єкції може виникати невелика кровотеча – це нормально.<o:p></o=
:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'margin-top:2.0pt;margin-ri=
ght:
    0cm;margin-bottom:6.0pt;margin-left:0cm;mso-add-space:auto'><span lang=
=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:8'>
    <td width=3D630 colspan=3D2 valign=3Dtop style=3D'width:472.65pt;border=
:solid windowtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'>КРОК
    9<o:p></o:p></span></b></p>
    <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DUK
    style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:U=
K'><o:p>&nbsp;</o:p></span></b></p>
    <p class=3DMsoListParagraphCxSpFirst align=3Dleft style=3D'margin-botto=
m:10.0pt;
    mso-add-space:auto;text-align:left;text-indent:-18.0pt;mso-list:l10 lev=
el1 lfo6'><![if !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"T=
imes New Roman";
    color:windowtext;mso-ansi-language:UK'><span style=3D'mso-list:Ignore'>=
•<span
    style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>Утилізуйте використаний ш=
приц
    згідно з інструкціями Вашого лікаря, медсестри або фармацевта відповідн=
о до
    вимог чинного законодавства.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpMiddle align=3Dleft style=3D'margin-bott=
om:10.0pt;
    mso-add-space:auto;text-align:left;text-indent:-18.0pt;mso-list:l10 lev=
el1 lfo6'><![if !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"T=
imes New Roman";
    color:windowtext;mso-ansi-language:UK'><span style=3D'mso-list:Ignore'>=
•<span
    style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>НІКОЛИ не одягайте ковпач=
ок
    на голку шприца після ін’єкції, Ви можете травмуватися.<o:p></o:p></spa=
n></p>
    <p class=3DMsoListParagraphCxSpMiddle style=3D'text-indent:-18.0pt;mso-=
list:
    l10 level1 lfo6'><![if !supportLists]><span lang=3DUK style=3D'mso-bidi=
-font-size:
    12.0pt;mso-fareast-font-family:"Times New Roman";color:windowtext;
    mso-ansi-language:UK'><span style=3D'mso-list:Ignore'>•<span
    style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>Не викидайте використані
    шприци разом із побутовим сміттям.<o:p></o:p></span></p>
    <p class=3DMsoListParagraphCxSpLast style=3D'text-indent:-18.0pt;mso-li=
st:l10 level1 lfo6'><![if !supportLists]><span
    lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"T=
imes New Roman";
    color:windowtext;mso-ansi-language:UK'><span style=3D'mso-list:Ignore'>=
•<span
    style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&n=
bsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span lang=3DUK style=3D'mso-bidi-font-s=
ize:
    12.0pt;color:windowtext;mso-ansi-language:UK'>Завжди тримайте шприц под=
алі
    від дітей.<o:p></o:p></span></p>
    </td>
   </tr>
   <tr style=3D'mso-yfti-irow:9;mso-yfti-lastrow:yes'>
    <td width=3D630 colspan=3D2 valign=3Dtop style=3D'width:472.65pt;border=
:solid windowtext 1.0pt;
    border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:
    solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
    <p class=3DMsoListParagraph style=3D'margin-left:0cm;mso-add-space:auto=
'><b
    style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi=
-font-size:
    12.0pt;mso-fareast-font-family:Calibri;color:windowtext;mso-ansi-langua=
ge:
    UK;mso-fareast-language:EN-US'><o:p>&nbsp;</o:p></span></b></p>
    </td>
   </tr>
  </table>
  <p class=3DMsoListParagraph style=3D'margin-left:0cm;mso-add-space:auto'>=
<span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Діти.
<o:p></o:p></span></h3>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'>Показаний для застосування дітям згідно з розділом «Показання».<b
style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Передозування.</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-weight:normal'><o:p></o:p=
></span></h3>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Максимал=
ьна
доза </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:window=
text;
mso-ansi-language:UK'>лікарського засобу Хуміра<sup>®</sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>, що переноситься людиною, не встановлена. У ході
клінічних досліджень адалімумабу не було виявлено випадків дозолімітуючої
токсичності. Пацієнтам призначалися багаторазові дози до 10 мг/кг, застосув=
ання
яких не супроводжувалось ознаками токсичності, пов’язаної із передозуванням=
. У
разі передозування необхідно спостерігати за станом пацієнта щодо появи
будь-яких симптомів побічних реакцій і негайно проводити відповідну
симптоматичну терапію.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h3 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Побічні
реакції.</span><s><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;text-tr=
ansform:
uppercase;font-weight:normal'><o:p></o:p></span></s></h3>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk16087124"><u=
><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK;mso-bidi-language:=
BO;
mso-bidi-font-style:italic'>Загальна інформація щодо профілю безпеки<o:p></=
o:p></span></u></a></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><a
name=3D"_Hlk138164884"></a><a name=3D"_Hlk152959867"><span style=3D'mso-boo=
kmark:
_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK'>Лікарський засіб Хуміра<sup>® </sup>досліджували </sp=
an></span></a></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>у контрольованих клінічних дослідженнях та </span></span></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>дослідженнях відкритого періоду тривалістю близько=
 60
місяців чи більше за участю 9506 пацієнтів. Ці дослідження включали пацієнт=
ів з
раннім та довготривалим ревматоїдним артритом, ЮРА (</span></span></span><s=
pan
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>поліартикулярним ювенільним ідіопатичним артритом та ентезит-асоційован=
им
артритом</span></span></span><span style=3D'mso-bookmark:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>), а так=
ож
із </span></span></span><span style=3D'mso-bookmark:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>аксіальним</span></span></spa=
n><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'> спондилоартритом (анкілозуючий спондиліт та
нерентгенографічний аксіальний спондилоартрит), псоріатичним артритом, хвор=
обою
Крона, виразковим колітом, псоріазом, гнійним гідраденітом, увеїтом. <o:p><=
/o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Нижче
приведено дані, отримані під час основних контрольованих досліджень, в яких
6089 пацієнтам застосовували </span></span></span><span style=3D'mso-bookma=
rk:
_Hlk16087124'><span style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарський
засіб Хуміра<sup>® </sup></span></span></span><span style=3D'mso-bookmark:_=
Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>та 3801
пацієнту застосовували плацебо або препарат порівняння впродовж контрольова=
ного
періоду. <o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Протягом основних клінічних
випробувань 5,9 % пацієнтів, які отримували лікарський засіб Хуміра<sup>®</=
sup>,
та 5,4 % пацієнтів з контрольної групи припинили лікування через побічні
реакції.<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Найчастіше повідомлялось про
виникнення побічних реакцій у вигляді інфекцій (таких як назофарингіт, </sp=
an></span></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>інфекції верхніх відділів дихальних шляхів та
синусит), реакцій в місці введення (почервоніння, свербіж, геморагії, біль =
або
набряк), головний біль та скелетно-м’язовий біль. <o:p></o:p></span></span>=
</span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Повідомлялося про серйозні
побічні реакції при застосуванні лікарського засобу Хуміра<sup>®</sup>.</sp=
an></span></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'> </span></span></=
span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Антагоністи ФНП, такі як Хуміра<sup>®</sup>, впливають на імунну систем=
у,
їх застосування може спричинити зниження опірності організму до інфекцій та
злоякісних новоутворень. <o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Під час застосування лікарськ=
ого
засобу Хуміра<sup>® </sup>повідомлялося про виникнення інфекцій, які можуть
становити загрозу життю людини та призвести до смерті (включаючи сепсис, </=
span></span></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>опортуністичні інфекції та туберкульоз</span></spa=
n></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>), про </span></span></span><span style=3D'mso-bookmark:_Hlk16087124'><=
span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>реактива=
цію
гепатиту В та виникнення різних новоутворень (включаючи лейкемію, </span></=
span></span><span
style=3D'mso-bookmark:_Hlk16087124'><span style=3D'mso-bookmark:_Hlk1381648=
84'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-font-style:italic'>лімфому та гепатолієнальну Т-клітинну лімфом=
у).<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>Повідомлялось також про серйо=
зні
гематологічні, неврологічні та аутоімунні реакції. Ці реакції включали
поодинокі випадки панцитопенії, апластичної анемії, випадки центральних та
периферичних </span></span></span><span style=3D'mso-bookmark:_Hlk16087124'=
><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>демієлін=
ізуючих
розладів, виникнення вовчака, </span></span></span><span style=3D'mso-bookm=
ark:
_Hlk16087124'><span style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>в=
овчакоподібних
станів та </span></span></span><span style=3D'mso-bookmark:_Hlk16087124'><s=
pan
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>синдрому
Стівенса – Джонсона.</span></span></span><span style=3D'mso-bookmark:_Hlk16=
087124'><span
style=3D'mso-bookmark:_Hlk138164884'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'> <o:p></o:p></span></span></s=
pan></p>

<span style=3D'mso-bookmark:_Hlk138164884'></span>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk16087124'><u><span
style=3D'color:windowtext'>Діти <o:p></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk16087124'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>Загалом побічні реакції у дітей були подібними за частотою та типом до =
тих,
що спостерігалися у дорослих пацієнтів.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk16087124'></span>

<p class=3DMsoNormal><u><span lang=3DUK style=3D'color:windowtext;mso-ansi-=
language:
UK'>Табличний перелік побічних реакцій<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>У таблиці 6 представлено пере=
лік
побічних реакцій, які спостерігалися протягом клінічних досліджень та
постреєстраційного спостереження,<span style=3D'mso-spacerun:yes'>  </span>=
за
органами і системами організму та частотою виникнення: &#8805; 1/10 – дуже
часто, від &#8805; 1/100 до &#706; 1/10 – часто; від &#8805; 1/1000 до &#70=
6; 1/100
– нечасто, від &#8805; 1/10000 до &#706; 1/1000 – рідко.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>Таблиця 6. <span style=3D'mso-bi=
di-font-weight:
bold'>Побічні реакції<b><o:p></o:p></b></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"100%"
 style=3D'width:100.0%;border-collapse:collapse;border:none;mso-border-alt:=
solid windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid;
  height:1.0pt'>
  <td width=3D"28%" valign=3Dtop style=3D'width:28.78%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;background=
:white'><b><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK'>Органи і системи організму</span></b><b><span lang=3DUK style=3D'mso-=
bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p><=
/o:p></span></b></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;background=
:white'><b><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Частота<o:p></o:p></span></b></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;background=
:white'><b><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Побічні реакції<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D3 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Інфекції та інвазії*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>інфекц=
ії
  дихальних шляхів (включаючи інфекції нижніх та верхніх відділів дихальних
  шляхів, пневмонію, синусит, фарингіт, ринофарингіт, пневмонію, спричинену
  вірусом герпесу)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>систем=
ні
  інфекції (включаючи сепсис, кандидоз та грип), <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>кишкові
  інфекції (включаючи вірусний гастроентерит),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><span
  style=3D'mso-spacerun:yes'> </span>інфекції шкіри та м’яких тканин (парон=
іхія, целюліт,
  імпетиго, некротичний фасциїт, оперізуючий герпес),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>інфекц=
ії
  вуха,<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><span
  style=3D'mso-spacerun:yes'> </span>інфекції ротової порожнини (включаючи =
вірус
  простого герпесу, герпес ротової порожнини та інфекції зубів),<o:p></o:p>=
</span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><span
  style=3D'mso-spacerun:yes'> </span>інфекції статевих органів (включаючи
  грибковий вульвовагініт),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>інфекц=
ії
  сечовивідних шляхів (включаючи пієлонефрит),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><span
  style=3D'mso-spacerun:yes'> </span>грибкові інфекції,<o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><span
  style=3D'mso-spacerun:yes'> </span>інфекції суглобів<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>неврол=
огічні
  інфекції (включаючи вірусний менінгіт),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>опорту=
ністичні
  інфекції і туберкульоз (включаючи кокцидіоїдомікоз, гістоплазмоз та інфек=
ції
  комплексу mycobacterium avium),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>бактер=
іальні
  інфекції, інфекції ока, дивертикуліт <sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Доброякісні, злоякісні<span
  style=3D'mso-spacerun:yes'>  </span>та неспецифічні новоутворення (включа=
ючи
  кісти та поліпи)*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>рак шк=
іри,
  за винятком меланоми (включаючи базальноклітинну карциному та плоскокліти=
нну
  карциному),<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>доброя=
кісні
  новоутворення<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>лімфом=
а**,
  <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>новоут=
ворення
  паренхіматозних органів (включаючи рак молочної залози, пухлину легенів та
  пухлину щитовидної залози), <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>мелано=
ма**<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>лейкем=
ія <sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>частота невідома<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>=
гепатолієнальна
  Т-клітинна лімфома <sup>1)</sup>,<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>=
карцинома
  з клітин Меркеля (нейроендокринна карцинома шкіри), <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-font-style:italic'>=
саркома
  Капоші</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
  mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку кровоносної та лімфатичної сист=
ем*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>лейкоп=
енія
  (включаючи нейтропенію та агранулоцитоз), анемія;<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>лейкоц=
итоз,
  тромбоцитопенія, <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>ідіопа=
тична
  тромбоцитопенічна пурпура;<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>панцит=
опенія<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D3 valign=3Dtop style=3D'width:28.78%;border-t=
op:none;
  border-left:solid windowtext 1.0pt;border-bottom:none;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-top-alt:solid windowt=
ext .5pt;
  mso-border-left-alt:solid windowtext .5pt;mso-border-right-alt:solid wind=
owtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку імунної системи*<o:p></o:p></sp=
an></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>гіперч=
утливість,
  алергія (включаючи сезонну алергію)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<span style=3D'mso-spacerun:yes'>  </span=
><o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>саркої=
доз <sup>1)</sup>,
  васкуліт <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>анафіл=
аксія
  <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:15;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-bottom:none;mso-border-top-alt:solid windowtext .5pt;mso-border-le=
ft-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення обміну речовин, метаболізму<o:p></o:p>=
</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>підвищ=
ення
  рівня ліпідів крові;<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:16;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>гіпока=
ліємія,
  гіперурикемія, відхилення від норми концентрації натрію у плазмі крові,
  гіпокальціємія, гіперглікемія, гіпофосфатемія, дегідратація<o:p></o:p></s=
pan></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:17;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" valign=3Dtop style=3D'width:28.78%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Психічні розлади<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>зміни
  настрою (включаючи депресію), тривога, безсоння<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:18;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Неврологічні розлади*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>головн=
ий
  біль<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:19;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>парест=
езія
  (включаючи гіпестезію), мігрень, стиснення нервових корінців<o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:20;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>поруше=
ння
  мозкового кровообігу<sup>1)</sup>, тремор, невропатія<o:p></o:p></span></=
p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:21;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>розсія=
ний
  склероз, демієлінізуючі розлади (наприклад неврит зорового нерва, синдром
  Гійєна – Барре)<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:22;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку органів зору<o:p></o:p></span><=
/p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>поруше=
ння
  гостроти зору, кон’юнктивіт, блефарит, набряк ока<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:23;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>диплоп=
ія<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:24;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку органів слуху та вестибулярного
  апарату<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>вертиг=
о<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:25;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>глухот=
а,
  дзвін у вухах<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:26;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D3 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Кардіальні порушення*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>тахіка=
рдія<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:27;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>інфаркт
  міокарда<sup>1)</sup>, аритмія, хронічна серцева недостатність<o:p></o:p>=
</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:28;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>зупинка
  серця<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:29;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Судинні розлади<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>артері=
альна
  гіпертензія, припливи, гематома<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:30;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>аневри=
зма
  аорти, оклюзія артерій, тромбофлебіт<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:31;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D3 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку дихальної системи, органів груд=
ної
  клітки та середостіння* <o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>астма,
  диспное, кашель<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:32;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>легене=
ва
  емболія<sup>1)</sup>, інтерстиціальне захворювання легенів, хронічне
  обструктивне захворювання легенів, пневмоніт, плевральний випіт<sup>1)</s=
up><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:33;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>легене=
вий
  фіброз<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:34;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Шлунково-кишкові розлади<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>біль у
  животі, нудота та блювання<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:35;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>шлунко=
во-кишкова
  кровотеча, диспепсія, гастроезофагеальний рефлюкс, сухий синдром (синдром
  Шегрена)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:36;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>панкре=
атит,
  дисфагія, набряк обличчя<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:37;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>перфор=
ація
  кишечнику<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:38;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Розлади гепатобіліарної системи*<o:p></o:p></spa=
n></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>підвищ=
ення
  рівня печінкових ферментів<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:39;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>холеци=
стит
  та холелітіаз, стеатоз печінки, підвищення рівня білірубіну<o:p></o:p></s=
pan></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:40;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>гепати=
т,
  реактивація гепатиту В<sup>1)</sup>, аутоімунний гепатит<sup>1)</sup><o:p=
></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:41;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>частота невідома<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>печінк=
ова
  недостатність<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:42;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D5 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Зміни з боку шкіри і підшкірної клітковини<o:p><=
/o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>висип
  (включаючи ексфоліативний висип)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:43;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>нові
  випадки або погіршення перебігу псоріазу (у тому числі долонно-підошовного
  пустульозного псоріазу)<sup>1)</sup>,<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>кропив=
’янка,
  екхімози (включаючи пурпуру), дерматит (включаючи екзему), оніхоклазія, п=
ідвищена
  пітливість, алопеція<sup>1)</sup>, свербіж<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:44;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>нічна
  пітливість, рубці<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:45;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>мульти=
формна
  еритема<sup>1)</sup>, синдром Стівенса – Джонсона<sup>1)</sup>, ангіоневр=
отичний
  набряк<sup>1)</sup>, шкірний васкуліт<sup>1)</sup>, ліхеноїдна реакція шк=
іри<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:46;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>частота невідома<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>погірш=
ення
  симптомів дерматоміозиту<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:47;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D4 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Порушення з боку опорно-рухової системи та сполу=
чної
  тканини<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>скелет=
но-м’язовий
  біль<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:48;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>спазми
  м’язів (включаючи підвищення рівня креатинфосфокінази у плазмі крові)<o:p=
></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:49;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>рабдом=
іоліз,
  системний червоний вовчак<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:50;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>рідко<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>вовчак=
оподібний
  синдром<sup>1)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:51;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Розлади з боку сечовидільної системи<o:p></o:p><=
/span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>ниркова
  недостатність, гематурія<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:52;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>ніктур=
ія<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:53;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" valign=3Dtop style=3D'width:28.78%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Розлади репродуктивної системи та молочних залоз=
<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>еректи=
льна
  дисфункція <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:54;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D3 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Загальні розлади та реакції у місці введення*<o:=
p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>дуже часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>реакці=
ї у
  місці введення (включаючи почервоніння у місці введення)<o:p></o:p></span=
></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:55;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>біль у
  грудях, набряк,</span><span lang=3DUK style=3D'color:windowtext;mso-ansi-=
language:
  UK'> </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wind=
owtext;
  mso-ansi-language:UK;mso-bidi-language:BO'>пірексія<sup>1)</sup><o:p></o:=
p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:56;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>нечасто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>запале=
ння<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:57;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"28%" rowspan=3D2 valign=3Dtop style=3D'width:28.78%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Обстеження*<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>коагул=
яція
  та порушення системи згортання крові (включаючи подовження активованого
  частково тромбопластинового часу (АЧТЧ)), позитивні тести на аутоантитіла
  (включаючи антитіла до дволанцюгової ДНК), підвищення рівня
  лактатдегідрогенази у плазмі крові<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:58;page-break-inside:avoid;height:1.0pt'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>частота невідома<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>збільш=
ення
  маси тіла<sup>2)</sup><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:59;mso-yfti-lastrow:yes;page-break-inside:avoid;
  height:1.0pt'>
  <td width=3D"28%" valign=3Dtop style=3D'width:28.78%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>Пошкодження, отруєння та процедурні ускладнення<=
o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal align=3Dleft style=3D'text-align:left;background:whi=
te'><span
  lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-la=
nguage:
  UK;mso-bidi-language:BO'>часто<o:p></o:p></span></p>
  </td>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.52%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt;height:1=
.0pt'>
  <p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'=
mso-bidi-font-size:
  12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>повіль=
не
  загоювання<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>* Див. також розділи «Протипоказання», «Особливості
застосування», «Побічні ефекти».<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>** Включаючи відкритий період
досліджень.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><sup><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>1) </span></sup><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Включаючи
дані спонтанних звітів.<o:p></o:p></span></p>

<p class=3DMsoNormal><sup><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
color:windowtext;mso-ansi-language:UK'>2) </span></sup><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Середня зміна маси тіла від
початкового рівня при застосуванні адалімумабу за показаннями для дорослих<=
span
style=3D'mso-spacerun:yes'>  </span>пацієнтів була в межах від 0,3 кг до 1,=
0 кг
порівняно з від (мінус) -0,4 кг до 0,4</span><span style=3D'color:windowtex=
t'>&nbsp;</span><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'>кг для групи плац=
ебо
протягом періоду лікування 4–6 місяців. Збільшення маси тіла на 5–6 кг також
спостерігали під час довгострокових досліджень із середньою тривалістю
експозиції приблизно 1–2 роки без контрольної групи, зокрема, у пацієнтів з
хворобою </span><span style=3D'color:windowtext'>Крона та виразковим коліто=
м.
Механізм, який зумовлює такий<span style=3D'mso-spacerun:yes'>  </span>ефек=
т,
невідомий, але, ймовірно, він пов’язаний з протизапальною дією адалімумабу.=
<span
style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><u><span lang=3DUK style=3D'color:windowtext;mso-ansi-=
language:
UK;mso-bidi-language:BO;mso-bidi-font-style:italic'>Увеїт<o:p></o:p></span>=
</u></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'>Профіль безпеки для пацієнтів з увеїтом, які отримували </span><a
name=3D"_Hlk152953608"><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;c=
olor:windowtext;
mso-ansi-language:UK'>лікарський засіб Хуміра<sup>® </sup></span></a><span
style=3D'mso-bookmark:_Hlk152953608'></span><span lang=3DUK style=3D'color:=
windowtext;
mso-ansi-language:UK'>кожні два тижні, відповідав відомому профілю безпеки =
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>®</sup></span><span lang=3DUK style=3D'co=
lor:
windowtext;mso-ansi-language:UK'>.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Опис окремих побічних реакцій<=
/span></h4>

<p class=3DMsoNormal><i><span lang=3DUK style=3D'color:windowtext;mso-ansi-=
language:
UK;mso-bidi-language:BO'>Реакції у місці введення<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях у дорослих та дітей, які отримували <=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-=
bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, у 12,9=
 %
випадків розвинулися реакції у місці введення (еритема та/або свербіж,
крововилив, біль або набряк), порівняно з 7,2 % пацієнтів<span
style=3D'mso-spacerun:yes'>  </span>з груп плацебо або активного контролю.
Реакції у місці введення загалом не потребували відміни препарату. <o:p></o=
:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Інфекції<span style=3D'mso-=
bidi-font-style:
italic'><o:p></o:p></span></span></i></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях у дорослих та дітей рівень інфекцій
становив 1,51/пацієнто-року у групі пацієнтів, які отримували </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-=
bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, та
1,46/пацієнто-року у групах плацебо або активного контролю. Переважно це бу=
ли
назофарингіт, інфекції верхніх дихальних шляхів та синусит. Більшість паціє=
нтів
продовжили застосовувати </span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарський засіб Хуміра<sup>® </sup>=
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>після одужання.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Рівень
серйозних інфекцій становив 0,04/пацієнто-року у групі пацієнтів, які
отримували </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:=
windowtext;
mso-ansi-language:UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>, та 0,03/пацієнто-року у групах плацебо або активного
контролю. У контрольованих та відкритих дослідженнях у дорослих та дітей
повідомлялося про розвиток тяжких інфекцій (рідко з летальним наслідком):
туберкульозу (у тому числі міліарного та позалегеневої локалізації) та
інвазивних опортуністичних інфекцій (наприклад, дисемінований чи позалегене=
вий
гістоплазмоз, бластомікоз, кокцидіоїдомікоз, пневмоцистна пневмонія, кандид=
оз,
аспергільоз, лістеріоз). Більшість випадків туберкульозу виникали протягом
перших восьми місяців після початку терапії та можуть являти собою рецидив
латентного захворювання.<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Новоутворення та
лімфопроліферативні розлади</span></i><span lang=3DUK style=3D'color:window=
text;
mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Протягом
клінічних досліджень адалімумабу у дітей з ЮРА (</span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>п=
оліартикулярним
артритом та ентезит-асоційованим артритом</span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>) злоякі=
сних
новоутворень не спостерігалося (n =3D 249, 655,6&nbsp;пацієнто-року).<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Додатков=
о не
спостерігалося злоякісних новоутворень у клінічних дослідженнях у дітей з
хворобою Крона (n =3D 192; 498,1 пацієнто-року), бляшковим псоріазом (n =3D=
 77;
80,0 пацієнто-року), увеїтом (n =3D 60; 58,4 пацієнто-року).</span><span la=
ng=3DUK
style=3D'color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Під час
контрольованих періодів основних досліджень <a name=3D"_Hlk152960233">засто=
сування
</a></span><span style=3D'mso-bookmark:_Hlk152960233'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарського
засобу Хуміра<sup>® </sup></span></span><span style=3D'mso-bookmark:_Hlk152=
960233'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>дорослим </span></span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>протягом
щонайменше 12 тижнів у пацієнтів з ревматоїдним артритом від середнього до
високого ступеня активності, пацієнтів із аксіальним спондилоартритом
(анкілозуючим спондилітом та нерентгенографічним аксіальним спондилоартрито=
м),
псоріатичним артритом, псоріазом, гнійним гідраденітом, хворобою Крона,
виразковим колітом та увеїтом рівень новоутворень (за винятком лімфоми та
немеланомного раку шкіри) становив (95 % довірчий інтервал) 6,8 (4,4; 10,5)=
 на
1000 пацієнто-років у 5291 пацієнта, які приймали </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарський
засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, в порівнянні з
рівнем 6,3 (3,4; 11,8) на 1000 пацієнто-років у 3444 пацієнтів контрольної
групи (середня тривалість лікування становила 4,0 місяця у групі застосуван=
ня </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарського засобу Хуміра<sup>® </sup></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>та 3,8 місяця у пацієнтів контрольної групи).<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Рівень
немеланомного раку шкіри (95 % довірчий інтервал) становив 8,8 (6,0; 13,0) =
на
1000 пацієнто-років у пацієнтів, які приймали </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарський
засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, та 3,2 (1,3; =
7,6)
на 1000 пацієнто-років у пацієнтів контрольної групи. Серед наведених випад=
ків
частота виникнення раку шкіри, плоскоклітинної карциноми (95 % довірчий
інтервал) становила 2,7(1,4; 5,4) на 1000 пацієнто-років у пацієнтів, які
приймали </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:wi=
ndowtext;
mso-ansi-language:UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK;
mso-bidi-language:BO'>, та 0,6 (0,1; 4,5) на 1000 пацієнто-років у пацієнтів
контрольної групи.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Рівень
лімфом (95 % довірчий інтервал) становив 0,7 (0,2; 2,7) на 1000 пацієнто-ро=
ків
у пацієнтів, які приймали </span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK'>лікарський засіб Хуміра<sup>®</sup><=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>, та 0,6 (0,1; 4,5) на 1000 пацієнто-років у паціє=
нтів
контрольної групи.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Частота =
розвитку
новоутворень (за винятком лімфоми та немеланомного раку шкіри) становила
приблизно 8,5/1000 пацієнто-років при поєднанні даних, отриманих<span
style=3D'mso-spacerun:yes'>  </span>у контрольованих дослідженнях та у відк=
ритих
дослідженнях, які ще тривають або вже завершені. В цьому об’єднаному аналізі
медіана спостереження становила приблизно 3,3 року, було включено 6427
пацієнтів та більш ніж 26439 пацієнто-років терапії. Частота розвитку
немеланомного раку шкіри становила приблизно 9,6/1000 пацієнто-років, а час=
тота
розвитку лімфом – приблизно 1,3/1000 пацієнто-років. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Під час
постреєстраційного спостереження з січня 2003 року по грудень 2010 року
переважно у пацієнтів з ревматоїдним артритом частота злоякісних новоутворе=
нь,
про які спонтанно повідомлялось, становила приблизно 2,7 на 1000 пацієнтів-=
років
лікування. Частота виникнення немеланомного раку шкіри та лімфом, про які с=
понтанно
повідомлялось, становила приблизно 0,2 та 0,3 на 1000 пацієнто-років лікува=
ння
відповідно (див. розділ «Особливості застосування»).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>Повідомл=
ялося
про рідкісні постреєстраційні випадки гепатолієнальної Т-клітинної лімфоми у
пацієнтів, які отримували адалімумаб (див. розділ «Особливості застосування=
»).<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'color:windowtext;mso-ansi-language:UK'>Аутоантитіла<span
style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></span></i></p>

<p class=3DMsoNormal style=3D'background:white'><a name=3D"_Hlk138167872"><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>У ході клінічних досліджень ревматоїдного артриту =
1–5
фаз пацієнтам декілька разів проводили аналіз крові на наявність аутоантиті=
л. У
цих дослідженнях при аналізі пацієнтів, що початково мали негативні титри
антинуклеарних антитіл, повідомлялось про позитивні титри на 24-му тижні у =
11,9
% пацієнтів, які приймали </span></a><span style=3D'mso-bookmark:_Hlk138167=
872'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span></span><span style=3D'mso-boo=
kmark:
_Hlk138167872'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:win=
dowtext;
mso-ansi-language:UK;mso-bidi-language:BO'>, та у 8,1 % пацієнтів груп плац=
ебо
або активного контролю</span></span><span style=3D'mso-bookmark:_Hlk1381678=
72'><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK'>.</span></span><s=
pan
style=3D'mso-bookmark:_Hlk138167872'><s><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'><o:p></o=
:p></span></s></span></p>

<p class=3DMsoNormal style=3D'background:white'><span style=3D'mso-bookmark=
:_Hlk138167872'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>У двох із 3441 пацієнта, які отримували </span></s=
pan><span
style=3D'mso-bookmark:_Hlk138167872'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK'>лікарський засіб Хуміра<sup>®=
 </sup></span></span><span
style=3D'mso-bookmark:_Hlk138167872'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>протягом
всіх клінічних випробувань РА та ПсА, розвинулися ознаки вперше виявленого
вовчакоподібного синдрому. Після припинення терапії стан пацієнтів покращив=
ся.
У жодного пацієнта не розвинулися люпус-нефрит або ураження центральної
нервової системи. </span></span><span style=3D'mso-bookmark:_Hlk138167872'>=
</span><span
style=3D'color:windowtext'><o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span
style=3D'color:windowtext'>Активність печінкових ферментів</span></i><span
style=3D'color:windowtext'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях 3 фази за участю пацієнтів з ревматої=
дним
артритом та псоріатичним артритом протягом контрольованого періоду триваліс=
тю
від 4 до 104 тижнів підвищення АЛТ (аланінтрансаміназа) у 3 або більше разів
від верхньої межі норми спостерігалося у 3,7 % пацієнтів, які отримували </=
span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-=
bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, та у 1=
,6 %
пацієнтів контрольної групи. <s><o:p></o:p></s></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях 3 фази за участю пацієнтів </span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>віком 4–17 років </span><span lang=3DUK style=3D'mso-bidi-font-size:12.=
0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>з </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>поліартикулярним</span><span lang=3DUK style=3D'color:windowtext;mso-an=
si-language:
UK'> </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:window=
text;
mso-ansi-language:UK'>ювенільним ревматоїдним (ідіопатичним) артритом та
пацієнтів віком 6–17 років з ентезит-асоційованим артритом </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>підвищення АЛТ у 3 або більше разів від верхньої м=
ежі
норми спостерігалося у 6,1 % пацієнтів, які отримували </span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарський
засіб Хуміра<sup>®</sup></span><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>, і 1,3 % паціє=
нтів
контрольної групи. Більшість випадків підвищення АЛТ спостерігалося під час
супутньої терапії метотрексатом. Не спостерігалось підвищення АЛТ у 3 або
більше разів від верхньої межі норми у клінічних дослідженнях 3 фази у
пацієнтів з поліартикулярним </span><span lang=3DUK style=3D'mso-bidi-font-=
size:
12.0pt;color:windowtext;mso-ansi-language:UK'>ювенільним ревматоїдним
(ідіопатичним) </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>артритом віком =
від
2 до 4 років.</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;colo=
r:windowtext;
mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих<span style=3D'mso-spacerun:yes'>  </span>клінічних досліджен=
нях 3
фази<span style=3D'mso-spacerun:yes'>  </span>за участю пацієнтів з хворобою
Крона та виразковим колітом з тривалістю контрольованого періоду від 4 до 52
тижнів підвищення АЛТ у 3 або більше разів від верхньої межі норми
спостерігалося у 0,9 % пацієнтів обох груп. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У клініч=
ному
дослідженні 3 фази за участю дітей з хворобою Крона, де було оцінено
ефективність та безпеку двократного відносно маси тіла режиму дозування з
подальшим приведенням до режиму дозування відповідно до маси тіла з тривалі=
стю
терапії до 52 тижнів, підвищення АЛТ в 3 або більше разів вище верхньої межі
норми спостерігалось у 2,6 % (5/192) пацієнтів, 4 з яких отримували </span>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso=
-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>на тлі
одночасного застосування імуносупресантів. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях 3 фази<span style=3D'mso-spacerun:yes=
'> 
</span>за участю пацієнтів з бляшковим псоріазом з тривалістю контрольного =
періоду
від 12 до 24 тижнів підвищення АЛТ у 3 або більше разів від верхньої межі н=
орми
спостерігалося у<span style=3D'mso-spacerun:yes'>  </span>1,8 % пацієнтів о=
бох
груп.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У клініч=
них
дослідженнях 3 фази у дітей з бляшковим псоріазом не спостерігалося підвище=
ння
АЛТ у 3 або більше разів від верхньої межі норми.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
контрольованих клінічних дослідженнях застосування </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарського
засобу Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у дорослих
пацієнтів з увеїтом тривалістю до 80 тижнів<b style=3D'mso-bidi-font-weight=
:normal'>
</b>(початкова доза 80 мг на тижні 0 і 40 мг 1 раз на 2 тижні, починаючи з
тижня 1) з медіаною терміну лікування 166,5 дня в групі </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарського
засобу Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>та 105,0 дня в
контрольній групі, підвищення АЛТ у 3 або більше разів від верхньої межи но=
рми
спостерігалося у 2,4&nbsp;% пацієнтів групи </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>л=
ікарського
засобу Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>та 2,4&nbsp;%
пацієнтів контрольної групи.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У клініч=
них
випробуваннях для всіх показань пацієнти мали безсимптомне підвищення рівня=
 АЛТ
і в більшості випадків підвищення було минущим і зникало на тлі продовження
лікування. Однак були постреєстраційні повідомлення про випадки печінкової
недостатності та менш серйозні печінкові реакції, що можуть призвести до
печінкової недостатності, такі як гепатит, включаючи аутоімунний гепатит, у
хворих, які отримували адалімумаб.<o:p></o:p></span></p>

<h4 style=3D'margin-top:0cm'><span lang=3DUK>Супутня терапія з азатіоприном=
/6-меркаптопурином</span></h4>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>У
дослідженнях у дорослих пацієнтів з хворобою Крона, які отримували </span><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK'>лікарський засіб Хуміра<sup>® </sup></span><span lang=3DUK style=3D'mso=
-bidi-font-size:
12.0pt;color:windowtext;mso-ansi-language:UK;mso-bidi-language:BO'>у комбін=
ації
з азатіоприном/6-меркаптопурином, спостерігалося підвищення частоти виникне=
ння
новоутворень та тяжких інфекцій порівняно з пацієнтами, які отримували
монотерапію </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color=
:windowtext;
mso-ansi-language:UK'>лікарським засобом Хуміра<sup>®</sup></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-lang=
uage:
UK;mso-bidi-language:BO'>.<o:p></o:p></span></p>

<h4><a name=3D"_Hlk152961511"><span lang=3DUK style=3D'mso-fareast-language=
:RU;
layout-grid-mode:line'>Повідомлення про підозрювані побічні реакції<o:p></o=
:p></span></a></h4>

<span style=3D'mso-bookmark:_Hlk152961511'></span>

<p class=3DMsoNormal style=3D'background:white'><span lang=3DUK style=3D'co=
lor:windowtext;
letter-spacing:.25pt;background:white;mso-ansi-language:UK'>Повідомлення про
побічні реакції після реєстрації лікарського засобу має важливе значення. Це
дає змогу проводити моніторинг співвідношення користь/ризик при застосуванні
цього лікарського засобу. Медичним та фармацевтичним працівникам, а також
пацієнтам або їхнім законним представникам слід повідомляти про усі випадки
підозрюваних побічних реакцій та відсутності ефективності лікарського засобу
через Автоматизовану інформаційну систему з фармаконагляду за посиланням: <=
/span><span
style=3D'color:windowtext'><a href=3D"https://aisf.dec.gov.ua/"><span lang=
=3DUK
style=3D'color:windowtext;letter-spacing:.25pt;background:white;mso-ansi-la=
nguage:
UK'>https://aisf.dec.gov.ua</span></a></span><span lang=3DUK style=3D'color=
:windowtext;
letter-spacing:.25pt;background:white;mso-ansi-language:UK'> </span><span
lang=3DUK style=3D'color:windowtext;mso-ansi-language:UK;mso-fareast-langua=
ge:RU;
layout-grid-mode:line'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK;mso-fareast-language:RU;layout-grid-mode:line'><o:p>&nbsp;</o:p></span><=
/p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK>Термін придатності.</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;layout=
-grid-mode:
line'> </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareas=
t-language:
RU;layout-grid-mode:line;font-weight:normal;mso-bidi-font-style:italic'>2 р=
оки.</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;layout=
-grid-mode:
line;mso-bidi-font-style:italic'><o:p></o:p></span></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Не слід застосовувати препарат після закінчення термі=
ну
придатності.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Умови
зберігання<span style=3D'text-transform:uppercase'>. <o:p></o:p></span></sp=
an></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Зберігати у недоступному для дітей місці при температ=
урі
від 2 до 8 °С (у холодильнику) в оригінальній картонній упаковці. Не
заморожувати.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Можливе зберігання при кімнатній температурі (не вище=
 25
°С) протягом не більше 14 діб у захищеному від світла місці. Не використову=
вати
через 14 діб після вилучення з холодильника (навіть якщо препарат був знову=
 поміщений
у холодильник).</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:windowtext;mso-ansi-language:UK;mso-fareast-language:RU;layout-grid-m=
ode:
line;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p></spa=
n></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Упаковка.<o:p></o:p></span></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>По 0,2 мл розчину у попередньо наповненому однодозово=
му
шприці. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:14.0pt;col=
or:windowtext;
mso-ansi-language:UK'>По 1 шприцу разом з 1 серветкою, просякнутою 70 %
ізопропіловим спиртом, вміщують у контурну чарункову упаковку. По 2 шприци =
(у контурній
чарунковій упаковці з 1 серветкою кожен) у картонній коробці.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Категорія
відпуску.</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-wei=
ght:
normal'><span style=3D'mso-spacerun:yes'>  </span>За рецептом.<o:p></o:p></=
span></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK>Виробник. </span></h2>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:windowtext;mso-ansi-language:UK'>В=
ипуск
серії. <o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Еббві Біотекнолоджі ГмбХ, Німеччина/ AbbVie Biotechno=
logy
GmbH, Germany.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin-top:0cm'><span lang=3DUK>Місцезнаходження виробника та =
його
адреса місця провадження діяльності. </span></h2>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;col=
or:windowtext;
mso-ansi-language:UK'>Кнольштрассе, 67061 Людвігсхафен, Німеччина/
Knollstrasse, 67061 Ludwigshafen, Germany.&nbsp;<span style=3D'mso-bidi-fon=
t-weight:
bold'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'color:windowtext;mso-ansi-lan=
guage:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-US style=3D'color:windowtext;mso-ansi-=
language:
EN-US'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns:b=3D"http://schemas.openxmlf=
ormats.org/officeDocument/2006/bibliography" xmlns=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{0B09B397-2315-441D-A34F-A85653D41506}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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==

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image001.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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==

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image002.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image003.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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==

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image004.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image005.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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==

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image006.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image007.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/image008.jpg
Content-Transfer-Encoding: base64
Content-Type: image/jpeg
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------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../UA168180101_C4B6.htm">
<![if IE]>
<base href=3D"file:///C:/68125876/UA168180101_C4B6.files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]>
</head>

<body lang=3DRU link=3D"#0563C1" vlink=3D"#954F72">

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-separato=
r'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-continua=
tion-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-separato=
r'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-continua=
tion-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dright style=3D'text-align:right'><!--[if suppo=
rtFields]><span
style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'> </span>PAGE<span style=3D'mso-spacerun:yes'>  
</span>\* MERGEFORMAT <span style=3D'mso-element:field-separator'></span><!=
[endif]--><span
style=3D'mso-no-proof:yes'>1</span><!--[if supportFields]><span style=3D'ms=
o-no-proof:
yes'><span style=3D'mso-element:field-end'></span></span><![endif]--></p>

<p class=3DMsoFooter><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>

------=_NextPart_01DD739E.3CD25FF0
Content-Location: file:///C:/68125876/UA168180101_C4B6.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA168180101_C4B6.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.jpg"/>
 <o:File HRef=3D"image002.jpg"/>
 <o:File HRef=3D"image003.jpg"/>
 <o:File HRef=3D"image004.jpg"/>
 <o:File HRef=3D"image005.jpg"/>
 <o:File HRef=3D"image006.jpg"/>
 <o:File HRef=3D"image007.jpg"/>
 <o:File HRef=3D"image008.jpg"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01DD739E.3CD25FF0--
